<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title>PLoS Pathogens</journal-title><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PLPA-RA-1652R2</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1000428</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry</subject><subject>Biochemistry/RNA Structure</subject><subject>Biochemistry/Structural Genomics</subject><subject>Biophysics</subject><subject>Biophysics/Protein Folding</subject><subject>Biophysics/RNA Structure</subject><subject>Biophysics/Structural Genomics</subject><subject>Virology/Emerging Viral Diseases</subject><subject>Virology/Viral Replication and Gene Regulation</subject><subject>Virology/Virulence Factors and Mechanisms</subject></subj-group></article-categories><title-group><article-title>The SARS-Unique Domain (SUD) of SARS Coronavirus Contains Two Macrodomains That Bind G-Quadruplexes</article-title><alt-title alt-title-type="running-head">The SARS-Unique Domain</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Jinzhi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vonrhein</surname><given-names>Clemens</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Smart</surname><given-names>Oliver S.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bricogne</surname><given-names>Gerard</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bollati</surname><given-names>Michela</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000b6;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kusov</surname><given-names>Yuri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hansen</surname><given-names>Guido</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mesters</surname><given-names>Jeroen R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Christian L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hilgenfeld</surname><given-names>Rolf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Institute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of L&#x000fc;beck, L&#x000fc;beck, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Global Phasing Ltd., Sheraton House, Castle Park, Cambridge, United Kingdom</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Laboratory for Structural Biology of Infection and Inflammation, c/o DESY, Hamburg, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rey</surname><given-names>F&#x000e9;lix A.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Institut Pasteur, France</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>hilgenfeld@biochem.uni-luebeck.de</email></corresp><fn id="fn1" fn-type="other"><label>&#x000b6;</label><p>On leave from the Department of Biomolecular Sciences &#x00026; Biotechnology, University of Milan, Milano, Italy</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: JT YK CLS RH. Performed the experiments: JT YK. Analyzed the data: JT CV GB MB GH JRM CLS RH. Contributed reagents/materials/analysis tools: CV OSS GB. Wrote the paper: JT RH.</p></fn></author-notes><pub-date pub-type="collection"><month>5</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>5</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>15</day><month>5</month><year>2009</year></pub-date><volume>5</volume><issue>5</issue><elocation-id>e1000428</elocation-id><history><date date-type="received"><day>22</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2009</year></date></history><copyright-statement>Tan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Since the outbreak of severe acute respiratory syndrome (SARS) in 2003, the three-dimensional structures of several of the replicase/transcriptase components of SARS coronavirus (SARS-CoV), the non-structural proteins (Nsps), have been determined. However, within the large Nsp3 (1922 amino-acid residues), the structure and function of the so-called SARS-unique domain (SUD) have remained elusive. SUD occurs only in SARS-CoV and the highly related viruses found in certain bats, but is absent from all other coronaviruses. Therefore, it has been speculated that it may be involved in the extreme pathogenicity of SARS-CoV, compared to other coronaviruses, most of which cause only mild infections in humans. In order to help elucidate the function of the SUD, we have determined crystal structures of fragment 389&#x02013;652 (&#x0201c;SUD<sub>core</sub>&#x0201d;) of Nsp3, which comprises 264 of the 338 residues of the domain. Both the monoclinic and triclinic crystal forms (2.2 and 2.8 &#x000c5; resolution, respectively) revealed that SUD<sub>core</sub> forms a homodimer. Each monomer consists of two subdomains, SUD-N and SUD-M, with a macrodomain fold similar to the SARS-CoV X-domain. However, in contrast to the latter, SUD fails to bind ADP-ribose, as determined by zone-interference gel electrophoresis. Instead, the entire SUD<sub>core</sub> as well as its individual subdomains interact with oligonucleotides known to form G-quadruplexes. This includes oligodeoxy- as well as oligoribonucleotides. Mutations of selected lysine residues on the surface of the SUD-N subdomain lead to reduction of G-quadruplex binding, whereas mutations in the SUD-M subdomain abolish it. As there is no evidence for Nsp3 entering the nucleus of the host cell, the SARS-CoV genomic RNA or host-cell mRNA containing long G-stretches may be targets of SUD. The SARS-CoV genome is devoid of G-stretches longer than 5&#x02013;6 nucleotides, but more extended G-stretches are found in the 3&#x02032;-nontranslated regions of mRNAs coding for certain host-cell proteins involved in apoptosis or signal transduction, and have been shown to bind to SUD <italic>in vitro</italic>. Therefore, SUD may be involved in controlling the host cell's response to the viral infection. Possible interference with poly(ADP-ribose) polymerase-like domains is also discussed.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The genome of the SARS coronavirus codes for 16 non-structural proteins that are involved in replicating this huge RNA (approximately 29 kilobases). The roles of many of these in replication (and/or transcription) are unknown. We attempt to derive conclusions concerning the possible functions of these proteins from their three-dimensional structures, which we determine by X-ray crystallography. Non-structural protein 3 contains at least seven different functional modules within its 1922-amino-acid polypeptide chain. One of these is the so-called SARS-unique domain, a stretch of about 338 residues that is completely absent from any other coronavirus. It may thus be responsible for the extraordinarily high pathogenicity of the SARS coronavirus, compared to other viruses of this family. We describe here the three-dimensional structure of the SARS-unique domain and show that it consists of two modules with a known fold, the so-called macrodomain. Furthermore, we demonstrate that these domains bind unusual nucleic-acid structures formed by consecutive guanosine nucleotides, where four strands of nucleic acid are forming a superhelix (so-called G-quadruplexes). SUD may be involved in binding to viral or host-cell RNA bearing this peculiar structure and thereby regulate viral replication or fight the immune response of the infected host cell.</p></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The SARS coronavirus (SARS-CoV) is much more pathogenic for humans than any other coronavirus. Therefore, protein domains encoded by the SARS-CoV genome that are absent in other coronaviruses are of particular interest, because they may be responsible for the extraordinary virulence. The most prominent such domain has been identified by bioinformatics as part of non-structural protein 3 (Nsp3) of the virus and appropriately named the &#x0201c;SARS-unique domain&#x0201d; (SUD) <xref ref-type="bibr" rid="ppat.1000428-Snijder1">&#x0005b;1&#x0005d;</xref>. With a molecular mass of 213 kDa, Nsp3 is the largest of the non-structural proteins of SARS coronavirus (see <xref ref-type="fig" rid="ppat-1000428-g001">Figure 1</xref>). Comprising 1922 amino-acid residues (polyprotein 1a/1ab residues Ala819 to Gly2740), SARS-CoV Nsp3 is larger than the entire replicase of <italic>Picornaviridae</italic>. It contains at least seven subdomains <xref ref-type="bibr" rid="ppat.1000428-Neuman1">&#x0005b;2&#x0005d;</xref>: An N-terminal acidic domain (Ac, also called Nsp3a); an X-domain (also designated as ADRP, or Nsp3b); the SUD (Nsp3c); a papain-like proteinase, PL2<sup>pro</sup> (also called Nsp3d); and additional domains (Nsp3e&#x02013;g) that include a transmembrane (TM) region.</p><fig id="ppat-1000428-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000428.g001</object-id><label>Figure 1</label><caption><title>Genome organisation of SARS-CoV.</title><p>Nsp3 and full-length SUD with subdomains N, M, and C are highlighted. M<sup>pro</sup>, main (or 3CL) protease; ssRBP, single-stranded RNA-binding protein; RdRp, RNA-dependent RNA polymerase; ExoN, exonuclease; NendoU, uridine-specific endoribonuclease; MT, methyltransferase; Spike, spike protein; E, envelope protein; M, membrane (matrix) protein; N, nucleocapsid protein; Ac, acidic domain; X, X-domain; SUD, SARS-unique domain; PL2<sup>pro</sup>, papain-like protease; TM, transmembrane region; Y, Y-domain.</p></caption><graphic xlink:href="ppat.1000428.g001"/></fig><p>At present, it is completely unclear whether and how the individual domains of Nsp3 interact with one another or with other components of the coronaviral replicase complex. Also, some of them possibly recognize proteins of the infected host cell <xref ref-type="bibr" rid="ppat.1000428-Neuman1">&#x0005b;2&#x0005d;</xref>. In the absence of functional data on these domains, attempts have been made to derive their possible biological role from their three-dimensional structures (see <xref ref-type="bibr" rid="ppat.1000428-Hilgenfeld1">&#x0005b;3&#x0005d;</xref> for a review). The NMR structure of an N-terminal fragment of the acidic domain (Nsp3a) has revealed a ubiquitin-like fold complemented by two additional short &#x003b1;-helices (<xref ref-type="bibr" rid="ppat.1000428-Serrano1">&#x0005b;4&#x0005d;</xref>, PDB code 2IDY). NMR chemical-shift analysis suggested that these non-canonical structural elements might bind single-stranded RNA with some specificity for AUA-containing sequences, although the K<sub>D</sub> values observed are relatively high (&#x0223c;20 &#x000b5;M). Interestingly, a second ubiquitin-like domain occurs in Nsp3, as part of the papain-like proteinase (PL2<sup>pro</sup>, Nsp3d, <xref ref-type="bibr" rid="ppat.1000428-Ratia1">&#x0005b;5&#x0005d;</xref>; PDB code 2FE8). The PL2<sup>pro</sup> cleaves the viral polyprotein after two consecutive glycine residues to release Nsp1, Nsp2, and Nsp3, respectively (The remaining cleavage reactions are performed by the coronaviral main proteinase (M<sup>pro</sup>; <xref ref-type="bibr" rid="ppat.1000428-Anand1">&#x0005b;6&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Tan1">&#x0005b;8&#x0005d;</xref>)). In addition to its proteolytic activities on the N-terminal third of the polyproteins, the SARS-CoV PL2<sup>pro</sup> has also been shown to be a deubiquitinating enzyme <xref ref-type="bibr" rid="ppat.1000428-Sulea1">&#x0005b;9&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Barretto2">&#x0005b;12&#x0005d;</xref>. Lindner <italic>et al</italic>. <xref ref-type="bibr" rid="ppat.1000428-Lindner2">&#x0005b;13&#x0005d;</xref> have shown that in addition to its proteolytic and deubiquitinating activity, the SARS-CoV PL2<sup>pro</sup> acts as a de-ISGylating enzyme. Induction of ISG15 and its subsequent conjugation to proteins protects cells from the effects of viral infection <xref ref-type="bibr" rid="ppat.1000428-Kim1">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Ritchie1">&#x0005b;15&#x0005d;</xref>. Since the ISG15 gene is induced by interferon as part of the antiviral response of the innate immune system, the de-ISGylation activity of Nsp3d could explain the suppression of the interferon response by the papain-like protease, in addition to a possible direct interaction between the PL2<sup>pro</sup> and IRF3 <xref ref-type="bibr" rid="ppat.1000428-Devaraj1">&#x0005b;16&#x0005d;</xref>.</p><p>Among the subdomains of the Nsp3 multidomain protein, there is also the so-called &#x0201c;X- domain&#x0201d; (Nsp3b), which shows structural homology to macrodomains. The latter name refers to the non-histone-like domain of the histone macro2A <xref ref-type="bibr" rid="ppat.1000428-Pehrson1">&#x0005b;17&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Chakravarthy1">&#x0005b;19&#x0005d;</xref>. In animal cells, such domains are occasionally physically associated with enzymes involved in ADP-ribosylation or ADP-ribose metabolism. Because of this linkage and on the basis of sequence similarity to Poa1p, a yeast protein involved in the removal of the 1&#x02033;-phosphate group from ADP-ribose 1&#x02033;-phosphate (a late step in tRNA splicing; <xref ref-type="bibr" rid="ppat.1000428-Shull1">&#x0005b;20&#x0005d;</xref>), it has been proposed that the coronaviral X-domains may have the function of ADP-ribose-1&#x02033;-phosphatases (ADRPs; <xref ref-type="bibr" rid="ppat.1000428-Putics1">&#x0005b;21&#x0005d;</xref>). The crystal structures of X-domains of SARS-CoV <xref ref-type="bibr" rid="ppat.1000428-Saikatendu1">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref> as well as of HCoV 229E and Infectious Bronchitis Virus (IBV) <xref ref-type="bibr" rid="ppat.1000428-Piotrowski1">&#x0005b;24&#x0005d;</xref> show that the protein has the three-layer &#x003b1;/&#x003b2;/&#x003b1; fold characteristic of the macrodomains.</p><p>Embedded between the X-domain (Nsp3b) and the PL2<sup>pro</sup> (Nsp3d), the SARS-unique domain (SUD; Nsp3c) fails to show sequence relationship to any other protein in the databases <xref ref-type="bibr" rid="ppat.1000428-Snijder1">&#x0005b;1&#x0005d;</xref>. We have produced full-length SUD (residues 389 to 726 of Nsp3), and a more stable, shortened 264-residue version (residues 389 to 652; henceforth called SUD<sub>core</sub>), by expression in <italic>Escherichia coli</italic>. This definition of the boundaries of the SUD is based on the structural results described here. We report crystallization of SUD<sub>core</sub> and its X-ray structure in two crystal forms, at 2.2 and 2.8 &#x000c5; resolution, respectively. The structure turns out to consist of two further copies of the macrodomain, in spite of the complete absence of sequence similarity. In addition, we demonstrate that each of the subdomains binds G-quadruplexes, both in DNA and RNA fragments, and that selected mutations of lysine residues in the first subdomain, SUD-N, lead to reduced nucleic-acid binding, whereas those in the second subdomain, SUD-M, abolish it.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Quality of the structural models</title><p>Out of the many SUD constructs designed and tested by us, SUD<sub>core</sub> (Nsp3 residues 389&#x02013;652) turned out to be relatively stable and could be crystallized (<xref ref-type="table" rid="ppat-1000428-t001">Table 1</xref>). Two crystal forms were observed under identical crystallization conditions: Form-1 crystals were monoclinic (space group P2<sub>1</sub>, two SUD<sub>core</sub> molecules per asymmetric unit) and diffracted X-rays to 2.2 &#x000c5; resolution; form-2 crystals were triclinic (space group P1, four SUD<sub>core</sub> molecules per asymmetric unit) and diffracted to 2.8 &#x000c5;. Both structures were determined by molecular replacement (see <xref ref-type="sec" rid="s4">Materials and Methods</xref>). The r.m.s. deviations (on C&#x003b1; atoms) between the models derived from the two different crystal structures are around 0.7 &#x000c5;.</p><table-wrap id="ppat-1000428-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000428.t001</object-id><label>Table 1</label><caption><title>Data collection and refinement statistics.</title></caption><graphic id="ppat-1000428-t001-1" xlink:href="ppat.1000428.t001"/><table frame="hsides" rules="groups" alternate-form-of="ppat-1000428-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Monoclinic crystal form</td><td align="left" rowspan="1" colspan="1">Triclinic crystal form</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Data collection</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Wavelength (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">1.25485</td><td align="left" rowspan="1" colspan="1">1.04123</td></tr><tr><td align="left" rowspan="1" colspan="1">Resolution (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">28.25&#x02013;2.22 (2.34&#x02013;2.22)</td><td align="left" rowspan="1" colspan="1">33.33&#x02013;2.80 (2.96&#x02013;2.80)</td></tr><tr><td align="left" rowspan="1" colspan="1">Space group</td><td align="left" rowspan="1" colspan="1">P2<sub>1</sub></td><td align="left" rowspan="1" colspan="1">P1</td></tr><tr><td align="left" rowspan="1" colspan="1">Unit-cell parameters</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">a (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">46.36</td><td align="left" rowspan="1" colspan="1">68.68</td></tr><tr><td align="left" rowspan="1" colspan="1">b (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">68.55</td><td align="left" rowspan="1" colspan="1">75.52</td></tr><tr><td align="left" rowspan="1" colspan="1">c (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">94.21</td><td align="left" rowspan="1" colspan="1">80.54</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1; (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">90.00</td><td align="left" rowspan="1" colspan="1">77.16</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b2; (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">99.17</td><td align="left" rowspan="1" colspan="1">75.61</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b3; (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">90.00</td><td align="left" rowspan="1" colspan="1">74.48</td></tr><tr><td align="left" rowspan="1" colspan="1">Solvent content (&#x00025;, v/v)</td><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">63</td></tr><tr><td align="left" rowspan="1" colspan="1">Overall reflections</td><td align="left" rowspan="1" colspan="1">166585 (7062)</td><td align="left" rowspan="1" colspan="1">101963 (9416)</td></tr><tr><td align="left" rowspan="1" colspan="1">Unique reflections</td><td align="left" rowspan="1" colspan="1">26598 (2508)</td><td align="left" rowspan="1" colspan="1">34003 (4086)</td></tr><tr><td align="left" rowspan="1" colspan="1">Multiplicity</td><td align="left" rowspan="1" colspan="1">6.3 (2.8)</td><td align="left" rowspan="1" colspan="1">3.0 (2.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Completeness (&#x00025;)</td><td align="left" rowspan="1" colspan="1">92.1 (61.0)</td><td align="left" rowspan="1" colspan="1">93.1 (76.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>R</italic><sub>merge</sub><xref ref-type="table-fn" rid="nt102">a</xref></td><td align="left" rowspan="1" colspan="1">0.055 (0.373)</td><td align="left" rowspan="1" colspan="1">0.075 (0.252)</td></tr><tr><td align="left" rowspan="1" colspan="1">I/&#x003c3;(I)</td><td align="left" rowspan="1" colspan="1">16.9 (2.0)</td><td align="left" rowspan="1" colspan="1">8.8 (2.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>R</italic><sub>pim</sub><xref ref-type="table-fn" rid="nt103">b</xref></td><td align="left" rowspan="1" colspan="1">0.025 (0.316)</td><td align="left" rowspan="1" colspan="1">0.056 (0.252)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Refinement</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>R</italic><sub>cryst</sub><xref ref-type="table-fn" rid="nt104">c</xref></td><td align="left" rowspan="1" colspan="1">0.211</td><td align="left" rowspan="1" colspan="1">0.223</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>R</italic><sub>free</sub><xref ref-type="table-fn" rid="nt104">c</xref></td><td align="left" rowspan="1" colspan="1">0.268</td><td align="left" rowspan="1" colspan="1">0.240</td></tr><tr><td align="left" rowspan="1" colspan="1">r.m.s.d. from ideal geometry</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">bonds (&#x000c5;)</td><td align="left" rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">angles (&#x000b0;)</td><td align="left" rowspan="1" colspan="1">1.295</td><td align="left" rowspan="1" colspan="1">1.188</td></tr><tr><td align="left" rowspan="1" colspan="1">Ramachandran plot regions</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Most favored (&#x00025;)</td><td align="left" rowspan="1" colspan="1">94.8</td><td align="left" rowspan="1" colspan="1">94.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Additionally allowed (&#x00025;)</td><td align="left" rowspan="1" colspan="1">4.6</td><td align="left" rowspan="1" colspan="1">4.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Outlier (&#x00025;)</td><td align="left" rowspan="1" colspan="1">0.6</td><td align="left" rowspan="1" colspan="1">0.7</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><p>Values in parentheses are for the highest resolution shell.</p></fn><fn id="nt102"><label>a</label><p><inline-formula><inline-graphic xlink:href="ppat.1000428.e001.jpg" mimetype="image"/></inline-formula>, where <italic>I</italic>(<italic>hkl</italic>) is the intensity of reflection <italic>hkl</italic> and <inline-formula><inline-graphic xlink:href="ppat.1000428.e002.jpg" mimetype="image"/></inline-formula> is the average intensity over all equivalent reflections.</p></fn><fn id="nt103"><label>b</label><p><italic>R</italic><sub>pim</sub> is the precision-indicating merging <italic>R</italic> factor <xref ref-type="bibr" rid="ppat.1000428-Weiss1">&#x0005b;78&#x0005d;</xref>.</p></fn><fn id="nt104"><label>c</label><p><inline-formula><inline-graphic xlink:href="ppat.1000428.e003.jpg" mimetype="image"/></inline-formula>. <italic>R<sub>free</sub></italic> was calculated for a test set of reflections (5&#x00025;) omitted from the refinement.</p></fn></table-wrap-foot></table-wrap><p>The models have good stereochemistry (<xref ref-type="table" rid="ppat-1000428-t001">Table 1</xref>). 94.7&#x00025; of the amino-acid residues are in the favoured regions of the Ramachandran plot and 4.6&#x00025; are in allowed regions. 0.6&#x00025; are outliers. In all six independent copies of the SUD<sub>core</sub> monomer, residue Val611 adopts forbidden conformational angles. This residue is located in a turn described by the polypeptide chain where it leaves the subdomain interface (see below) and reaches the surface of the molecule. The side chain makes a hydrophobic contact across the subdomain interface and is also contacting the side chain of Phe406 of a symmetry-related SUD<sub>core</sub> dimer in the crystal lattice in the monoclinic crystal form (this also applies to two of the four monomers in the triclinic form).</p></sec><sec id="s2b"><title>Overall structure</title><p>SUD<sub>core</sub> exhibits a two-domain architecture (<xref ref-type="fig" rid="ppat-1000428-g002">Figure 2A</xref>). The N-terminal subdomain (SUD-N) comprises Nsp3 residues 389&#x02013;517, and the C-terminal subdomain of SUD<sub>core</sub> contains residues 525&#x02013;652. We call the latter the &#x0201c;middle SUD subdomain&#x0201d;, or SUD-M, because full-length SUD has a C-terminal extension of 74 residues compared to SUD<sub>core</sub>. The SUD-N and SUD-M subdomains have a similar fold and can be superimposed with an r.m.s.d. of 3.3&#x02013;3.4 &#x000c5; (based on C&#x003b1; positions); they share 11&#x00025; sequence identity (see <xref ref-type="fig" rid="ppat-1000428-g002">Figure 2C</xref> for a structural alignment). Of the 14 amino-acid residues identical between the two subdomains, four form a conserved Leu-Glu-Glu-Ala motif at the N-terminus of helix &#x003b1;4. The linker between the two subdomains (residues 518&#x02013;524) has no visible electron density. This is due to elevated mobility of the linker, rather than proteolytic cleavage, since we showed by SDS-PAGE of dissolved crystals that the SUD<sub>core</sub> polypeptide (in the presence of &#x003b2;-mercaptoethanol) has the apparent molecular mass to be expected (&#x0223c;29 kDa; not shown). In addition to the linker, SUD-N and SUD-M are connected by a disulfide bond between cysteines 492 and 623 (<xref ref-type="fig" rid="ppat-1000428-g002">Figure 2B</xref>). Disulfide bonds are rare in cytosolic proteins, but in coronaviral Nsps, examples of such bonds have been reported <xref ref-type="bibr" rid="ppat.1000428-Ponnusamy1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Cao1">&#x0005b;26&#x0005d;</xref>.</p><fig id="ppat-1000428-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000428.g002</object-id><label>Figure 2</label><caption><title>Structure of the SUD<sub>core</sub> monomer and comparison with the SARS-CoV X-domain.</title><p>(A) Ribbon representation of the SUD<sub>core</sub> structure (residues 389&#x02013;652 of Nsp3). The flexible linker connecting the two macrodomains is indicated by a dotted line. The disulfide bond between cysteines 492 of SUD-N and 623 of SUD-M is shown in orange. (B) Stereo image of the 2F<sub>o</sub>&#x02013;F<sub>c</sub> electron-density map (1&#x003c3; above the mean) around the disulfide bond connecting the SUD-N and SUD-M subdomains. (C) Structure-based sequence alignment of the SUD<sub>core</sub> subdomains N (SUD-N) and M (SUD-M), and the SARS-CoV X-domain (SARS-X). &#x003b1;-Helices and &#x003b2;-strands are marked red and blue, respectively. Residues 518&#x02013;524 form the linker between the two SUD subdomains and have not been included in the alignment. Asterisks mark SARS-X residues involved in binding of ADP-ribose. (D) Superimposition of the structures of the SUD-N (violet) and SUD-M (green) subdomains with the SARS-CoV X-domain (cyan).</p></caption><graphic xlink:href="ppat.1000428.g002"/></fig><p>The fold of each SUD subdomain is that of a macrodomain (<xref ref-type="fig" rid="ppat-1000428-g002">Figure 2A</xref>). Macrodomains consist of a largely parallel central &#x003b2;-sheet surrounded by 4&#x02013;6 &#x003b1;-helices. The order of regular secondary-structure elements in SUD-N is &#x003b2;N1-&#x003b1;N1-&#x003b2;N2-&#x003b1;N2-&#x003b2;N3-&#x003b2;N4-&#x003b1;N3-&#x003b2;N5-&#x003b1;N4-&#x003b2;N6, and in SUD-M &#x003b2;M1-&#x003b1;M1-&#x003b2;M2-&#x003b1;M2-&#x003b2;M3-&#x003b2;M4-&#x003b1;M3-&#x003b2;M5-&#x003b1;M4-&#x003b2;M6-&#x003b1;M5. The topology of the &#x003b2;-strands is &#x003b2;1&#x02013;&#x003b2;6&#x02013;&#x003b2;5&#x02013;&#x003b2;2&#x02013;&#x003b2;4&#x02013;&#x003b2;3, all of which are parallel except &#x003b2;3 (<xref ref-type="fig" rid="ppat-1000428-g002">Figure 2A</xref>). Between the two subdomains, most of the secondary-structure elements are conserved with respect to their position in the three-dimensional structure, although they often differ in length. This is particularly obvious for &#x003b1;-helix 1, which comprises just four residues in the N-terminal subdomain but eleven in the M subdomain. Similarly, &#x003b1;-helix 2 has 5 vs. 10 amino-acid residues in the two subdomains. In general, the strands of the central &#x003b2;-sheet appear to align better between the two subdomains than do the &#x003b1;-helices.</p><p>Each of the SUD<sub>core</sub> subdomains is related to the macrodomain of the histone macro2A (<xref ref-type="bibr" rid="ppat.1000428-Kustatscher1">&#x0005b;18&#x0005d;</xref>; PDB code 1ZR3, molecule C; for SUD-N: Z-score 9.8, r.m.s.d. 2.5 &#x000c5; for 112 out of 184 C&#x003b1; atoms, 12&#x00025; sequence identity; for SUD-M: Z-score 8.6, r.m.s.d. 2.8 &#x000c5; for 115 out of 184 C&#x003b1; atoms, 19&#x00025; sequence identity). Called &#x0201c;X-domains&#x0201d;, single macrodomains are also found in alphaviruses, in hepatitis E virus, and in rubella virus, in addition to coronaviruses <xref ref-type="bibr" rid="ppat.1000428-Koonin1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Neuvonen1">&#x0005b;28&#x0005d;</xref>. The SARS-CoV X-domain (Nsp3b), the domain immediately preceding the SUD in Nsp3, shares no recognizable sequence identity with SUD-N (12&#x00025;) or SUD-M (7&#x00025;) (<xref ref-type="fig" rid="ppat-1000428-g002">Figure 2C</xref>), but its three-dimensional structure <xref ref-type="bibr" rid="ppat.1000428-Saikatendu1">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref> (PDB code 2ACF, chain A) can be superimposed onto each of the two SUD subdomains with an r.m.s.d. (based on C&#x003b1; atoms) of 2.7 &#x000c5; and 2.3 &#x000c5;, respectively (<xref ref-type="fig" rid="ppat-1000428-g002">Figure 2D</xref>). Thus, within Nsp3, SARS-CoV has three macrodomains aligned one after the other.</p><p>In both crystal forms, SUD<sub>core</sub> displays the same head-to-tail dimer, with the SUD-N subdomain of monomer A interacting with the SUD-M subdomain of monomer B, and <italic>vice versa</italic>. Approximately 1130 &#x000c5;<sup>2</sup> of solvent-accessible surface per monomer is buried upon dimerization (<xref ref-type="fig" rid="ppat-1000428-g003">Figure 3</xref>). Due to the two-domain architecture of each monomer, the resulting four lobes give the dimer a quasi-tetrahedral shape (<xref ref-type="fig" rid="ppat-1000428-g003">Figure 3A</xref>). Involving &#x0223c;10 hydrogen bonds and four well-defined salt-bridges (AspB440&#x02026;ArgA554, ArgB473&#x02026;GluA619, ArgB554&#x02026;AspA440, and GluB619&#x02026;ArgA473), interactions between the monomers are largely hydrophilic. As to be expected, the structures of the monomers are very similar to one another, with r.m.s.d. values (for C&#x003b1; atoms) of 0.58 &#x000c5; between monomers A and B of the monoclinic crystal form, and 0.11&#x02013;0.37 &#x000c5; between monomers A&#x02013;D of the triclinic form. The structure of SUD-M alone is even better conserved between the individual copies of SUD<sub>core</sub>. Also, the fold of the SUD-M subdomain is similar to the model of the SUD fragment 527&#x02013;651 derived from NMR measurements, which was published very recently (r.m.s.d. &#x0223c;0.9 &#x000c5;) <xref ref-type="bibr" rid="ppat.1000428-Chatterjee1">&#x0005b;29&#x0005d;</xref>.</p><fig id="ppat-1000428-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000428.g003</object-id><label>Figure 3</label><caption><title>Structure of the SUD<sub>core</sub> dimer.</title><p>(A) SUD<sub>core</sub> forms a head-to-tail dimer. SUD-N and SUD-M of monomer A are colored violet and cyan, respectively, and SUD-N and SUD-M of monomer B are colored magenta and green, respectively. (B) Surface of the SUD<sub>core</sub> homodimer colored according to electrostatic potential (blue, positive potential; red, negative potential). Orientation is the same as in the cartoon representation in (A). The extended patches of positive potential (blue) are possible binding sites for G-quadruplexes or other nucleic acids. (C) As (B), but rotated by 180&#x000b0;. The narrow cleft running across the dimer surface (with a &#x0223c;45&#x000b0; orientation relative to the monomer-monomer interface, which runs horizontal in this illustration) could be a potential protein-binding site. The monomer&#x02013; monomer interface is largely hydrophilic and buries &#x0223c;1130 &#x000c5;<sup>2</sup> of exposed surface per monomer.</p></caption><graphic xlink:href="ppat.1000428.g003"/></fig></sec><sec id="s2c"><title>The SUD<sub>core</sub> macrodomains fail to bind ADP-ribose</title><p>The function of the coronaviral X-domain is still unclear; for some coronaviruses such as HCoV 229E and SARS-CoV, it has been shown to exhibit a low ADP-ribose-1&#x02033;-phosphate phosphatase (Appr-1&#x02033;-pase, occasionally also called &#x0201c;ADRP&#x0201d;) activity and to bind the product of the reaction, ADP-ribose <xref ref-type="bibr" rid="ppat.1000428-Putics1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Putics2">&#x0005b;30&#x0005d;</xref>. However, the two subdomains of SUD<sub>core</sub> do not bind ADP-ribose, as we have demonstrated by zone-interference gel electrophoresis (<xref ref-type="supplementary-material" rid="ppat.1000428.s001">Figure S1</xref>).</p></sec><sec id="s2d"><title>SUD<sub>core</sub> and its individual subdomains bind G-quadruplexes</title><p>When we investigated possible interactions between SUD and nucleic acids by zone-interference gel electrophoresis, we found that the domain binds oligo(G) and oligo(dG) stretches with a K<sub>D</sub> of &#x0223c;1 &#x000b5;M, but not oligo(dA), (dC), or (dT) <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>. Single-stranded nucleotides of random sequence are only bound if they are longer than &#x0223c;15 nucleotides. Here we demonstrate that each of the two individual SUD subdomains also binds oligo(dG) (<xref ref-type="fig" rid="ppat-1000428-g004">Figure 4A</xref>). With oligo(dH), where H stands for A, C, or T, but not G, only very small gel shifts, if at all, were observed. As oligo(G) stretches are known to form G-quadruplexes, i.e. four-stranded nucleic-acid structures formed by contiguous guanines <xref ref-type="bibr" rid="ppat.1000428-Keniry1">&#x0005b;32&#x0005d;</xref>, we also examined the binding to the oligodeoxynucleotide <named-content content-type="gene">5&#x02032;-GGGCGCGGGAGGAATTGGGCGGG-3&#x02032;</named-content>, a G-rich sequence present in the <italic>bcl-2</italic> promoter region. This oligonucleotide has been shown by NMR spectroscopy to form a G-quadruplex (<xref ref-type="bibr" rid="ppat.1000428-Dai1">&#x0005b;33&#x0005d;</xref>; PDB code 2F8U). We found that both full-length SUD and SUD<sub>core</sub> do indeed bind this oligodeoxynucleotide and that this process is enhanced by the addition of K<sup>&#x0002b;</sup> ions, which are known to stabilize G-quadruplex structures (<xref ref-type="fig" rid="ppat-1000428-g004">Figure 4B</xref>). In agreement with the ability of SUD to non-specifically bind to oligonucleotides of &#x0003e;15 bases <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>, both SUD and SUD<sub>core</sub> were found to bind the reverse-complementary sequence, but with low affinity and, more importantly, independent of K<sup>&#x0002b;</sup> ions.</p><fig id="ppat-1000428-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000428.g004</object-id><label>Figure 4</label><caption><title>Binding of oligonucleotides to SUD as demonstrated by zone-interference gel electrophoresis.</title><p>Protein concentration was 10 &#x000b5;M in all experiments. (A) Binding of increasing concentrations (indicated above the lanes) of (dG)<sub>10</sub> to the SUD-N and SUD-M subdomains of SUD<sub>core</sub> (left and right panel, resp.). Comparison with 32 &#x000b5;M (dA)<sub>10</sub>, (dC)<sub>10</sub>, or (dT)<sub>10</sub> shows that the binding is specific for (dG)<sub>10</sub>. &#x0201c;H&#x0201d; stands for A, C, or T. (B) Binding of increasing concentrations (indicated above the lanes) of the quadruplex-forming oligodeoxynucleotide <named-content content-type="gene">5&#x02032;-GGGCGCGGGAGGAATTGGGCGGG-3&#x02032;</named-content> (labeled &#x0201c;Bcl-2&#x0201d;) as occurring within the <italic>bcl-2</italic> promoter region, in the presence and absence of 100 mM KCl, which is known to promote quadruplex formation. Left panel, full-length SUD; right panel, SUD<sub>core</sub>. The reverse-complementary oligodeoxynucleotide (labeled &#x0201c;rc&#x0201d;), which fails to form a quadruplex but exceeds the minimum length of &#x0223c;15 nucleotides for non-quadruplex interaction with SUD, is also bound, but with reduced affinity and independently of KCl. (dG)<sub>10</sub> (labeled &#x0201c;G&#x0201d;) has been included as a positive control. (C) Binding of increasing concentrations (indicated above the lanes) of the quadruplex-forming oligoribonucleotide <named-content content-type="gene">5&#x02032;-UGGGGGGAGGGAGGGAGGGA-3&#x02032;</named-content> (labeled &#x0201c;RNA&#x0201d;) as occurring in the 3&#x02032;-nontranslated region of chicken elastin mRNA. Left panel: interaction with full-length SUD; right panel: interaction with SUD<sub>core</sub>. Binding of (dG)<sub>10</sub> (labeled &#x0201c;G&#x0201d;) is shown for comparison. 100 mM KCl was present in all lanes. (D) Binding to SUD<sub>core</sub> of the quadruplex-forming oligonucleotide <named-content content-type="gene">5&#x02032;-UGGGGU-3&#x02032;</named-content> (labeled &#x0201c;UG<sub>4</sub>U&#x0201d;) in the presence (left) and absence (right) of 100 mM KCl. (dG)<sub>10</sub> (labeled &#x0201c;G&#x0201d;) has been included as a positive control.</p></caption><graphic xlink:href="ppat.1000428.g004"/></fig><p>As there is no evidence for SARS-CoV Nsp3 entering the nucleus and binding to DNA, we examined whether SUD would bind to an RNA known to form a quadruplex structure. Indeed, zone-interference gel shift experiments revealed major shifts for both SUD and SUD<sub>core</sub> in the presence of the oligoribonucleotide <named-content content-type="gene">5&#x02032;-UGGGGGGAGGGAGGGAGGGA-3&#x02032;</named-content>, which is a protein-binding element in the 3&#x02032;-nontranslated region of chicken elastin mRNA <xref ref-type="bibr" rid="ppat.1000428-Hew1">&#x0005b;34&#x0005d;</xref> and forms G-quadruplexes <xref ref-type="bibr" rid="ppat.1000428-Pan1">&#x0005b;35&#x0005d;</xref> (<xref ref-type="fig" rid="ppat-1000428-g004">Figure 4C</xref>). Furthermore, we observed a significant gel shift for SUD<sub>core</sub> when we added the short oligonucleotide UGGGGU, which has also been shown to form a G-quadruplex (<xref ref-type="bibr" rid="ppat.1000428-Deng1">&#x0005b;36&#x0005d;</xref>; PDB code 1J8G). This shift was also enhanced by the addition of K<sup>&#x0002b;</sup> (<xref ref-type="fig" rid="ppat-1000428-g004">Figure 4D</xref>). Thus, SUD binds RNA (rG)-quadruplexes and DNA (dG)-quadruplexes with comparable affinity.</p></sec><sec id="s2e"><title>Effect of lysine mutations on G-quadruplex binding</title><p>Inspection of the structure of the SUD dimer reveals a central narrow cleft running across the dimer surface, but distinct from the monomer-monomer interface (<xref ref-type="fig" rid="ppat-1000428-g003">Figure 3C</xref>), which could be a binding site for another protein. In addition, there are several positively charged patches in the center of the dimer (<xref ref-type="fig" rid="ppat-1000428-g003">Figure 3B</xref>), and on its backside (<xref ref-type="fig" rid="ppat-1000428-g003">Figure 3C</xref>), which could be involved in binding to G-quadruplexes. We have prepared four sets of mutations by replacing lysine residues (and one glutamate) in these patches by alanines. The first two pairs of mutations, K505A&#x0002b;K506A (M1, at the end of helix &#x003b1;N4) and K476A&#x0002b;K477A (M2, in the loop between &#x003b1;N3 and &#x003b2;N5), are located on the surface of the SUD-N subdomain and lead to reduced shifts with G-quadruplexes in the zone-interference gel electrophoresis experiment, both with the G-quadruplex from the <italic>bcl-2</italic> promoter region (<xref ref-type="fig" rid="ppat-1000428-g005">Figure 5</xref>) and with (dG)<sub>10</sub> (not shown). The second set of mutations, K563A&#x0002b;K565A&#x0002b;K568A (M3) and K565A&#x0002b;K568A&#x0002b;E571A (M4) are located in the loop connecting &#x003b1;M2 and &#x003b2;M3 of the SUD-M subdomain and abolish G-quadruplex binding altogether (<xref ref-type="fig" rid="ppat-1000428-g005">Figure 5</xref>), again with both oligonucleotides.</p><fig id="ppat-1000428-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1000428.g005</object-id><label>Figure 5</label><caption><title>G-quadruplex binding is affected by mutations of lysine residues on the surface of SUD<sub>core</sub>.</title><p>Binding of double and triple mutants of SUD<sub>core</sub> to the quadruplex-forming oligodeoxynucleotide <named-content content-type="gene">5&#x02032;-GGGCGCGGGAGGAATTGGGCGGG-3&#x02032;</named-content> as occurring within the <italic>bcl-2</italic> promoter region, in the presence of 100 mM KCl, as demonstrated by zone-interference gel electrophoresis. Protein concentration was 10 &#x000b5;M in all experiments. Oligonucleotide at two concentrations (4 and 16 &#x000b5;M) was added to wild-type SUD<sub>core</sub> and mutants M1 (K505A&#x0002b;K506A), M2 (K476A&#x0002b;K477A), M3 (K563A&#x0002b;K565A&#x0002b;K568A), and M4 (K565A&#x0002b;K568A&#x0002b;E571A). Mutants M1 and M2 show reduced shifts, in particular at 4 &#x000b5;M nucleotide, whereas mutants M3 and M4 abolish binding. Note that in the absence of nucleotide, mutant proteins M3 and M4 behave differently on the gel because of different charges.</p></caption><graphic xlink:href="ppat.1000428.g005"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>When the SARS-unique domain was first predicted <xref ref-type="bibr" rid="ppat.1000428-Snijder1">&#x0005b;1&#x0005d;</xref>, the boundaries of the domain were set approximately at Nsp3 residues 352 and 726. We made major efforts to produce this protein in a stable form, but with little success. Only when we used <italic>in-vitro</italic> protein synthesis, were we able to obtain small amounts of a relatively stable preparation comprising Nsp3 residues 349&#x02013;726 <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>. At the N-terminus of this construct, up to eleven residues actually correspond to the C-terminus of the preceding X-domain (Nsp3b). When we expressed a gene construct coding for SUD (349&#x02013;726) in <italic>E. coli</italic>, we observed rapid proteolytic degradation of the N-terminal segment. The relatively stable intermediate obtained had its N-terminus at Nsp3 residue 389. The N-terminal segment &#x0223c;359&#x02013;388 is predicted to be intrinsically unfolded by several prediction programs (not shown). Therefore, we assume segment 359&#x02013;388 to be merely a linker between Nsp3b and SUD, and 389 to be the first residue of the latter. This assignment is justified by the observation that in our crystal structures reported here, the SUD-N subdomain is a complete macrodomain without any residues lacking at the N-terminus. Therefore, the protein corresponding to Nsp3 residues 389&#x02013;726 is called &#x0201c;full-length SUD&#x0201d; here.</p><p>In this communication, we describe the crystal structures at 2.2 &#x000c5; and 2.8 &#x000c5; resolution (monoclinic and triclinic form, respectively) of the core of the SARS-unique domain (SUD<sub>core</sub>, Nsp3 residues 389&#x02013;652). SUD<sub>core</sub> turns out to consist of two subdomains, SUD-N (Nsp3 residues 389&#x02013;517) and SUD-M (525&#x02013;652), each exhibiting the fold of a macrodomain. The two subdomains are connected by a flexible linker (residues 518&#x02013;524) and a disulfide bond. Even though coronavirus replication occurs in the cytosol, where the environment is reductive, it is unlikely that the formation of this disulfide is an artifact owing to handling of the protein: As the linker between the SUD-N and SUD-M subdomains is very short (seven residues), and the mutual orientation of the subdomains is fixed due to the tight dimerization, cysteine residues no. 492 and 623 will be very close to one another irrespective of the exact conformation of the linker. In fact, disulfide bonds are not uncommon in coronaviral non-structural proteins (Nsps) involved in RNA replication or transcription. Among others, they have been observed in HCoV-229E Nsp9 <xref ref-type="bibr" rid="ppat.1000428-Ponnusamy1">&#x0005b;25&#x0005d;</xref> and turkey coronavirus Nsp15 <xref ref-type="bibr" rid="ppat.1000428-Cao1">&#x0005b;26&#x0005d;</xref>, but in these cases, the disulfide bond connects two subunits of the homo-oligomeric proteins, whereas the occurrence in SUD<sub>core</sub> is the first case of an <italic>intra</italic>molecular disulfide bond described in a coronavirus Nsp.</p><p>Coronavirus replication in the perinuclear region of the cell is localized to double-membrane vesicles that have been hijacked from the endoplasmic reticulum or late endosomes <xref ref-type="bibr" rid="ppat.1000428-Prentice1">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Knoops1">&#x0005b;40&#x0005d;</xref>. These vesicles are around 200&#x02013;350 nm in diameter and present alone or as clusters in the cytosol <xref ref-type="bibr" rid="ppat.1000428-Snijder2">&#x0005b;38&#x0005d;</xref>. The milieu inside or at the surface of these vesicles is unknown, but it is well possible that it is partially oxidative. It has also been speculated <xref ref-type="bibr" rid="ppat.1000428-Ponnusamy1">&#x0005b;25&#x0005d;</xref> that formation of disulfide bonds may be a way for the coronaviral Nsps to function in the presence of the oxidative stress that is the consequence of the viral infection <xref ref-type="bibr" rid="ppat.1000428-Eleouet1">&#x0005b;41&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Imai1">&#x0005b;43&#x0005d;</xref>.</p><p>Our identification of two macrodomains in SUD<sub>core</sub> brings the number of these domains in SARS-CoV Nsp3 to three. What are the functions of these modules? The original SARS-CoV &#x0201c;X-domain&#x0201d; (Nsp3b) has been shown to have low ADP-ribose-1&#x02033;-phosphate phosphatase (Appr-1&#x02033;-pase or &#x0201c;ADRP&#x0201d;) activity <xref ref-type="bibr" rid="ppat.1000428-Putics1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref>. However, this assignment is controversial. A nuclear Appr-1&#x02033;-pase (Poa1p in yeast, <xref ref-type="bibr" rid="ppat.1000428-Shull1">&#x0005b;20&#x0005d;</xref>) is an enzyme of a tRNA metabolic pathway, but there is no evidence for coronavirus Nsp3 ever being translocated to the nucleus, and the other enzymes involved in this pathway are missing in coronaviruses (with the exception of the cyclic 1&#x02033;,2&#x02033;-phosphodiesterase (CPDase) in group 2a viruses such as Mouse Hepatitis Virus, Bovine Coronavirus, and Human Coronavirus OC43). Therefore, it has been proposed that the X-domain may be involved in binding poly(ADP-ribose), a metabolic product of NAD<sup>&#x0002b;</sup> synthesized by the enzyme poly(ADP-ribose) polymerase (PARP; <xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref>). However, we have recently demonstrated that the X-domain of Infectious Bronchitis Virus (IBV) strain Beaudette, a group-3 coronavirus, does not have significant affinity to ADP-ribose <xref ref-type="bibr" rid="ppat.1000428-Piotrowski1">&#x0005b;24&#x0005d;</xref>. This can be explained on the basis of crystal structures: In the X-domain (Nsp3b) of SARS-CoV <xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref>, and in that of HCoV 229E <xref ref-type="bibr" rid="ppat.1000428-Piotrowski1">&#x0005b;24&#x0005d;</xref>, a stretch of three conserved glycine residues is involved in binding the pyrophosphate unit of ADP-ribose, whereas in the corresponding domain of IBV strain Beaudette (but not in all IBV strains, see <xref ref-type="bibr" rid="ppat.1000428-Xu1">&#x0005b;44&#x0005d;</xref>), the second glycine is replaced by serine, leading to steric interference with ADP-ribose binding <xref ref-type="bibr" rid="ppat.1000428-Piotrowski1">&#x0005b;24&#x0005d;</xref>. In the two SUD subdomains, the triple-glycine sequence is not conserved (see <xref ref-type="fig" rid="ppat-1000428-g002">Figure 2C</xref>), and hence, they do not bind ADP-ribose either.</p><p>Neuman <italic>et al.</italic><xref ref-type="bibr" rid="ppat.1000428-Neuman1">&#x0005b;2&#x0005d;</xref> reported that full-length SUD binds cobalt ions, whereas a domain called SUD-C by these authors, which is however almost identical (residues 513&#x02013;651) to our SUD-M (525&#x02013;652), does not. From this, they concluded that the metal-binding activity is associated with the cysteine residues in the N-terminal subdomain. We were also able to observe binding of cobalt ions to SUD<sub>core</sub> by following the occurrence of a peak at 310 nm in the UV spectrum, which, in contrast to the data presented by Neuman <italic>et al</italic>. <xref ref-type="bibr" rid="ppat.1000428-Neuman1">&#x0005b;2&#x0005d;</xref>, could be reverted by addition of zinc ions. However, when we removed the N-terminal His-tag, this phenomenon could no longer be observed. Furthermore, we note that of the four cysteine residues in the SUD-N subdomain (residues 393, 456, 492, and 507), 456 and 507 are non-accessible in the interior of the subdomain, and 492 is involved in the buried disulfide bond to Cys623; therefore, Cys393 and perhaps the solvent-exposed His423 would remain the only potential ligands for cobalt ions in SUD-N. However, these residues are &#x0003e;12 &#x000c5; apart and thus unlikely to chelate cobalt ions.</p><p>For SUD-M, a recent publication <xref ref-type="bibr" rid="ppat.1000428-Chatterjee1">&#x0005b;29&#x0005d;</xref> reported binding to oligo(A). However, we fail to observe this (<xref ref-type="fig" rid="ppat-1000428-g004">Figure 4A</xref>, lane labeled &#x0201c;A&#x0201d;). Instead, we have demonstrated that full-length SUD and SUD<sub>core</sub> bind oligodeoxynucleotides and oligoribonucleotides that form G-quadruplexes. For full-length SUD and SUD<sub>core</sub>, we had previously shown binding to oligo(dG) and oligo(G) stretches <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>, but the demonstration here of oligo(dG) binding to the individual SUD<sub>core</sub> subdomains, SUD-N and SUD-M, is unexpected because their overall electrostatic properties are very different from one another: SUD-N is acidic (pI&#x0200a;&#x0003d;&#x0200a;5.3), whereas SUD-M is basic (pI&#x0200a;&#x0003d;&#x0200a;9.0). However, even SUD-N shows surface patches with positive electrostatics that could bind nucleic acid (<xref ref-type="fig" rid="ppat-1000428-g003">Figure 3B</xref>).</p><p>We have used automatic docking procedures to place the G-quadruplex found in the <italic>bcl-2</italic> promoter region (<xref ref-type="bibr" rid="ppat.1000428-Dai1">&#x0005b;33&#x0005d;</xref>; PDB code 2F8U) into our crystal structures. One potential binding site identified is in the cleft between the SUD-M and the SUD-N subdomains within the SUD<sub>core</sub> dimer (<xref ref-type="supplementary-material" rid="ppat.1000428.s002">Figure S2A</xref>); this binding site is spatially close to the mutations M3 and M4, consistent with the observation that these mutations abolish binding completely. However, we have previously shown by Dynamic Light-Scattering that G-quadruplex binding leads to oligomerization of SUD<sub>core</sub><xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>. Consequently, we have also constructed models based on the packing modes of SUD<sub>core</sub> dimers observed in our crystal structures. One potential binding site for G-quadruplexes might be in a cleft between two consecutive SUD<sub>core</sub> dimers as they occur in both the monoclinic and triclinic crystal forms (<xref ref-type="supplementary-material" rid="ppat.1000428.s002">Figure S2B</xref>), but for confirmation, any of these models will have to await crystallographic determination of the complex. In summary, our mutation experiments demonstrate an involvement of several of the many lysine residues of SUD in binding G-quadruplexes, but as it is probably extended surfaces of SUD<sub>core</sub> oligomers that participate in this process, it is not possible to pinpoint any single amino-acid residue.</p><p>The target of SUD binding could be G-quadruplexes in RNA of viral or/and cellular origin. The SARS-CoV genome contains three G<sub>6</sub>-stretches (one on the plus-strand and two on the minus-strand) and an additional two G<sub>5</sub>-sequences, which could perhaps form local G-quadruplexes. However, the G-stretch binding capabilities of SUD and SUD<sub>core</sub> seem to have been optimized for recognition of longer G-rich sequences. By systematic variation of the length of oligo(dG), we found that SUD<sub>core</sub> exhibits strongest affinity (K<sub>D</sub> &#x0223c;0.45 &#x000b5;M) for (dG)<sub>10</sub> to (dG)<sub>14</sub><xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>. The 3&#x02032;-nontranslated regions of several host-cell mRNAs coding for proteins involved in the regulation of apoptosis and in signaling pathways contain long G-stretches and could also be targets of SUD. Examples of such mRNAs are those coding for the pro-apoptotic protein Bbc3 <xref ref-type="bibr" rid="ppat.1000428-Wie1">&#x0005b;45&#x0005d;</xref>, RAB6B (a member of the Ras oncogene family, <xref ref-type="bibr" rid="ppat.1000428-GarciaSaez1">&#x0005b;46&#x0005d;</xref>), MAP kinase 1 <xref ref-type="bibr" rid="ppat.1000428-Mizutani1">&#x0005b;47&#x0005d;</xref>, and TAB3, a component of the NF-&#x003ba;B signaling pathway <xref ref-type="bibr" rid="ppat.1000428-Jin1">&#x0005b;48&#x0005d;</xref>. It is conceivable that these proteins might be targets for the virus when interfering with cellular signaling. Changes in the stability and/or translation efficiency of these mRNAs due to the binding of a viral regulatory factor could result in an altered reaction of the infected cell to apoptotic signals, or it could silence the antiviral response.</p><p>The idea that coronaviral X-domains might function as modules binding poly(ADP-ribose) <xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref> received support from the observation that some macrodomains are connected with domains showing poly(ADP-ribose) polymerase (PARP) activity, i.e. in the so-called macroPARPs (PARP-9 and PARP-14) <xref ref-type="bibr" rid="ppat.1000428-Hakm1">&#x0005b;49&#x0005d;</xref>. There are 18 human genes for members of the PARP family; the prototype enzyme, PARP-1, catalyzes the post-translational modification of many substrate proteins, including itself, in a multitude of cellular processes (DNA repair, transcriptional regulation, energy metabolism, and apoptosis) <xref ref-type="bibr" rid="ppat.1000428-Brkle1">&#x0005b;50&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Hassa1">&#x0005b;52&#x0005d;</xref>. Interestingly, SUD-M and the C-terminal 74-residue subdomain (SUD-C) that is missing in our SUD<sub>core</sub> construct together show a &#x0223c;15&#x00025; sequence identity (32&#x00025; similarity) to the catalytic domain of PARP-1. However, the three-dimensional structures of SUD-M (this work) and the C-terminal domain of PARP-1 <xref ref-type="bibr" rid="ppat.1000428-Ruf1">&#x0005b;53&#x0005d;</xref> are different and cannot be superimposed. Another feature common between SARS-CoV SUD and PARP-1 is that the latter has recently been shown to bind to G-quadruplexes <xref ref-type="bibr" rid="ppat.1000428-Soldatenkov1">&#x0005b;54&#x0005d;</xref>, although it is generally assumed that this occurs through the DNA-binding domain rather than the catalytic domain of PARP-1.</p><p>PARP-1 and most of its family members are located to the nucleus, while PARP-4 and others predominantly act in the cytoplasm <xref ref-type="bibr" rid="ppat.1000428-Brkle1">&#x0005b;50&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="ppat.1000428-Hassa1">&#x0005b;52&#x0005d;</xref>. PARP-4 is incorporated into vaults, RNA-containing subcellular particles in the cytoplasm <xref ref-type="bibr" rid="ppat.1000428-vanZon1">&#x0005b;55&#x0005d;</xref>. Furthermore, ZAP, a human antiviral protein comprising a C-terminal PARP-like domain devoid of catalytic activity, has been shown to exhibit antiviral activity on alphaviruses <xref ref-type="bibr" rid="ppat.1000428-Kerns1">&#x0005b;56&#x0005d;</xref>, which contain an X-domain similar to that of coronaviruses <xref ref-type="bibr" rid="ppat.1000428-Egloff1">&#x0005b;23&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Koonin1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Neuvonen1">&#x0005b;28&#x0005d;</xref>. In addition, ZAP contains an N-terminal zinc-finger domain, a central TiPARP (2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD)-inducible PARP) domain, and a WWE domain (a protein-protein interaction module in ubiquitin and ADP-ribose conjugation proteins). In fact, ZAP appears to be part of the human innate immune system and to play a role comparable to APOBEC3G in HIV infection <xref ref-type="bibr" rid="ppat.1000428-GoilaGaur1">&#x0005b;57&#x0005d;</xref>. It is possible that this group of viruses has evolved macrodomains to counteract the antiviral activity of ZAP. Indeed, macrodomains can inhibit PARPs, as has been shown for the macrodomain of the histone mH2A1.1, which downregulates the catalytic activity of PARP-1 <xref ref-type="bibr" rid="ppat.1000428-Ouararhni1">&#x0005b;58&#x0005d;</xref>. Having three macrodomains at its disposal, SARS-CoV may be much more efficient in knocking down the antiviral response of the host cell than other coronaviruses. Whether this involves a direct interaction between SUD and ZAP or another member of the PARP family, or competition for G-quadruplexes in viral or host-cell RNA, remains to be shown.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Recombinant protein production and purification</title><p>Full-length SUD (Nsp3 residues 389&#x02013;726) and the fragment SUD<sub>core</sub> (Nsp3 residues 389&#x02013;652, previously called &#x0201c;SUDc5b&#x0201d;) of SARS-CoV strain TOR2 (acc. no. AY274119) were produced recombinantly in <italic>E. coli</italic> as described <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>. The coding regions for the SUD-N subdomain (Nsp3 residues 389&#x02013;524) and the SUD-M subdomain (Nsp3 residues 525&#x02013;652) were constructed by introducing an appropriate deletion into the previously described plasmid pQE30-Xa-c5b <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref> using site-directed mutagenesis. Plasmids encoding SUD-N and SUD-M were prepared using primers listed in <xref ref-type="supplementary-material" rid="ppat.1000428.s003">Table S1</xref>. The coding regions for four sets of mutations of SUD<sub>core</sub>, M1 (K505A&#x0002b;K506A), M2 (K476A&#x0002b;K477A), M3 (K563A&#x0002b;K565A&#x0002b;K568A), and M4 (K565A&#x0002b;K568A&#x0002b;E571A), were constructed by introducing appropriate mutations into plasmid pQE30-Xa-c5b <xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref> using site-directed mutagenesis. Plasmids encoding these mutants were prepared using primers also listed in <xref ref-type="supplementary-material" rid="ppat.1000428.s003">Table S1</xref>. All plasmids provided an N-terminal His-tag and a short linker sequence encoding a factor-Xa cleavage site. The coding regions of the expression plasmids were verified by DNA sequencing. <italic>E. coli</italic> M15 (pRep4) was used as expression host for these constructs. SUD-N, SUD-M, and the mutated proteins were purified according to the same protocol as for SUD<sub>core</sub><xref ref-type="bibr" rid="ppat.1000428-Tan2">&#x0005b;31&#x0005d;</xref>.</p></sec><sec id="s4b"><title>Crystallization</title><p>SUD<sub>core</sub> displayed &#x0003e;95&#x00025; purity in SDS-PAGE, and monodispersity in Dynamic Light- Scattering. Initial crystallization screening was performed using the sitting-drop vapor-diffusion method in 96-well Intelli-Plates (Dunn Laboratories). Several commercial kits (Sigma, Jena Bioscience) were used for the screening. The protein concentration was 6 mg/ml. Using a Phoenix robotic system (Art Robbins), drops were made of 260 nl protein and 260 nl precipitant solution. The optimized crystallization condition consisted of 20&#x00025; polyethylene glycol monomethyl ether 5000 and 0.2 M ammonium sulfate in 0.1 M morpholinoethane sulfonic acid (pH 6.5). Plate-like crystals grew in 3&#x02013;5 days, to maximum dimensions of 0.02&#x000d7;0.02&#x000d7;0.01 mm<sup>3</sup>.</p></sec><sec id="s4c"><title>Data collection and processing</title><p>Many SUD<sub>core</sub> crystals had to be tested for diffraction until one yielding data to 2.2 &#x000c5; resolution was found. The best diffracting crystals belonged to space group P2<sub>1</sub>. Under the same crystallization conditions, a second crystal form belonging to space group P1 was observed, diffracting to lower resolution of about 2.8 &#x000c5;. Crystals were cryoprotected in reservoir solution that included 30&#x00025; glycerol, and were harvested into a loop prior to flash-cooling in liquid nitrogen. All data were collected at 100 K from a single crystal each at beamline BL14.2, BESSY (Berlin, Germany), using an MX225 CCD detector (Rayonics), or at beamline I911-2 at MAX-lab (Lund, Sweden), using a Mar165 CCD detector (Marresearch). Data were processed with MOSFLM <xref ref-type="bibr" rid="ppat.1000428-Leslie1">&#x0005b;59&#x0005d;</xref>, and reduced and scaled using the SCALA <xref ref-type="bibr" rid="ppat.1000428-Evans1">&#x0005b;60&#x0005d;</xref> program from the CCP4 suite <xref ref-type="bibr" rid="ppat.1000428-Collaborative1">&#x0005b;61&#x0005d;</xref>. Crystals belonging to space group P2<sub>1</sub> had unit-cell parameters <italic>a</italic>&#x0200a;&#x0003d;&#x0200a;46.36 &#x000c5;, <italic>b</italic>&#x0200a;&#x0003d;&#x0200a;68.55 &#x000c5;, <italic>c</italic>&#x0200a;&#x0003d;&#x0200a;94.21 &#x000c5;, <italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;99.17&#x000b0;, those belonging to space group P1 had unit-cell parameters <italic>a</italic>&#x0200a;&#x0003d;&#x0200a;68.68 &#x000c5;, <italic>b</italic>&#x0200a;&#x0003d;&#x0200a;75.52 &#x000c5;, <italic>c</italic>&#x0200a;&#x0003d;&#x0200a;80.54 &#x000c5;, &#x003b1;&#x0200a;&#x0003d;&#x0200a;77.16&#x000b0;, <italic>&#x003b2;</italic>&#x0200a;&#x0003d;&#x0200a;75.61&#x000b0;, &#x003b3;&#x0200a;&#x0003d;&#x0200a;74.48&#x000b0;. Data-collection statistics for both crystal forms are shown in <xref ref-type="table" rid="ppat-1000428-t001">Table 1</xref>. The asymmetric unit of the P2<sub>1</sub> form contained two SUD<sub>core</sub> monomers, giving a Matthews coefficient <xref ref-type="bibr" rid="ppat.1000428-Matthews1">&#x0005b;62&#x0005d;</xref> of 2.5 &#x000c5;<sup>3</sup> Da<sup>&#x02212;1</sup> and a solvent content of 51&#x00025;, whereas the P1 crystal form had four monomers per asymmetric unit, giving corresponding parameters of 3.2 &#x000c5;<sup>3</sup> Da<sup>&#x02212;1</sup> and 63&#x00025;.</p></sec><sec id="s4d"><title>Structure determination</title><p>We attempted to solve the structure by molecular replacement into the P2<sub>1</sub> form using the NMR coordinates of a subdomain comprising SARS-CoV Nsp3 residues 513&#x02013;651; PDB code 2JWJ <xref ref-type="bibr" rid="ppat.1000428-Chatterjee1">&#x0005b;29&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-Chatterjee2">&#x0005b;63&#x0005d;</xref>), which is almost identical to the SUD-M subdomain of SARS-CoV Nsp3. Using the program Phaser <xref ref-type="bibr" rid="ppat.1000428-McCoy1">&#x0005b;64&#x0005d;</xref>,<xref ref-type="bibr" rid="ppat.1000428-McCoy2">&#x0005b;65&#x0005d;</xref>, we could find two solutions, and the C-terminal part of SUD<sub>core</sub> was well defined in the electron-density maps. However, for the N-terminal half, only a few segments of poly(Ala) chain could be built into the maps. This starting model was then refined in BUSTER-TNT <xref ref-type="bibr" rid="ppat.1000428-Bricogne1">&#x0005b;66&#x0005d;</xref> using Local Structure Similarity Restraints (LSSR) <xref ref-type="bibr" rid="ppat.1000428-Smart1">&#x0005b;67&#x0005d;</xref> as non-crystallographic symmetry (NCS) restraints to give R and R<sub>free</sub> values of 0.453 and 0.479, respectively. The resulting 2mF<sub>o</sub>-DF<sub>c</sub> electron density was subjected to density modification using solvent flattening, histogram matching, and 2-fold NCS-averaging using DM <xref ref-type="bibr" rid="ppat.1000428-Cowtan1">&#x0005b;68&#x0005d;</xref>. The averaging masks were calculated and updated using the auto-correlation procedure <xref ref-type="bibr" rid="ppat.1000428-Vellieux1">&#x0005b;69&#x0005d;</xref> as implemented in DM. Using the automatic building program BUCCANEER <xref ref-type="bibr" rid="ppat.1000428-Cowtan2">&#x0005b;70&#x0005d;</xref> together with REFMAC <xref ref-type="bibr" rid="ppat.1000428-Murshudov1">&#x0005b;71&#x0005d;</xref> (as implemented in the CCP4i <xref ref-type="bibr" rid="ppat.1000428-Potterton1">&#x0005b;72&#x0005d;</xref> interface for CCP4) in an iterative procedure for 20 cycles resulted in a model for 501 residues in 10 chains (the longest having 208 residues), in which 448 residues were assigned both a chemical identity and a sequential residue number, while the remaining 53 residues were modeled as poly(Ala) in 8 shorter chains. The R and R<sub>free</sub> values resulting from REFMAC were 0.374 and 0.414, respectively. This model was refined in BUSTER-TNT, again using LSSR as NCS restraints for the common parts in the already sequenced 448 residues of the dimer, to R and R<sub>free</sub> values of 0.269 and 0.316. The improved electron density was again subjected to density modification using DM as detailed above, but using a lower solvent content of 35&#x00025; as well as anisotropically scaled observed amplitudes as output by BUSTER-TNT. The resulting density-modified and NCS-averaged map was then used for automatic model building using the iterative BUCCANEER/REFMAC procedure described above. This produced a model with 511 residues in 5 chains with 487 residues sequenced. The R and R<sub>free</sub> values from REFMAC for this model were 0.289 and 0.326, respectively.</p><p>Since the refinements in BUSTER-TNT at that point showed some problematic low correlations between F<sub>o</sub> and F<sub>c</sub> at low resolution, the original images collected from the P2<sub>1</sub> crystal were reprocessed using XDS <xref ref-type="bibr" rid="ppat.1000428-Kabsch1">&#x0005b;73&#x0005d;</xref> and SCALA, applying different high-resolution cutoffs for different segments of the collected images. Details for this dataset are given in <xref ref-type="table" rid="ppat-1000428-t001">Table 1</xref>. Subsequent refinement of the P2<sub>1</sub> form with REFMAC, under application of weak NCS restraints, yielded a model with R&#x0200a;&#x0003d;&#x0200a;0.211, R<sub>free</sub>&#x0200a;&#x0003d;&#x0200a;0.264. The advanced handling of NCS restraints through LSSR in BUSTER-TNT gave a final model R&#x0200a;&#x0003d;&#x0200a;0.211 and R<sub>free</sub>&#x0200a;&#x0003d;&#x0200a;0.268. The final model in the P2<sub>1</sub> form comprises 513 residues (A389&#x02013;A516; A524&#x02013;A652; B393&#x02013;B519; B526&#x02013;B652).</p><p>Chain A of the P2<sub>1</sub> form was used for molecular replacement with the program MOLREP <xref ref-type="bibr" rid="ppat.1000428-Vagin1">&#x0005b;74&#x0005d;</xref> into the P1 form. There was an unambiguous solution for four molecules in the asymmetric unit. This model was refined with BUSTER-TNT (using LSSR for NCS restraints) and rebuilt in Coot <xref ref-type="bibr" rid="ppat.1000428-Emsley1">&#x0005b;75&#x0005d;</xref> to final values of R&#x0200a;&#x0003d;&#x0200a;0.223 and R<sub>free</sub>&#x0200a;&#x0003d;&#x0200a;0.240. The final model of the P1 form comprises 1014 residues.</p><p>The figures were made with PyMOL <xref ref-type="bibr" rid="ppat.1000428-DeLano1">&#x0005b;76&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Zone-interference gel electrophoresis (ZIGE)</title><p>The zone-interference gel electrophoresis (ZIGE) device was adapted from Abrahams <italic>et al.</italic><xref ref-type="bibr" rid="ppat.1000428-Abrahams1">&#x0005b;77&#x0005d;</xref>. ZIGE assays were performed using a horizontal 1&#x00025; agarose gel system in TBE buffer (20 mM Tris, 50 mM boric acid, 0.1 mM ethylenediaminetetraacetic acid (EDTA), pH 8.3). The protein was incubated at room temperature for 30 min with different concentrations of oligodeoxynucleotides, such as (dG)<sub>10</sub> and <italic>bcl-2</italic> promoter region (<named-content content-type="gene">5&#x02032;-GGGCGCGGGAGGAATTGGGCGGG-3&#x02032;</named-content>), or oligoribonucleotides (<named-content content-type="gene">5&#x02032;-UGGGGGGAGGGAGGGAGGGA-3&#x02032;</named-content> and <named-content content-type="gene">5&#x02032;-UGGGGU-3&#x02032;</named-content>). The samples were mixed with dimethylsulfoxide (DMSO; final concentration 10&#x00025; (v/v)) and a trace of bromophenolblue (BPB). These protein-oligonucleotide samples were applied to the small slots. Oligonucleotide with the same concentration as in the small slots was also mixed with DMSO and BPB in 1xTBE buffer and applied to the long slots of the gel (total volume 100 &#x000b5;l). Electrophoresis was performed at 4&#x000b0;C for 1 h with a constant current of 100 mA. Staining was performed as outlined in <xref ref-type="bibr" rid="ppat.1000428-Abrahams1">&#x0005b;77&#x0005d;</xref>.</p></sec><sec id="s4f"><title>Accession Codes</title><p>Protein Data Bank: Coordinates and structure factors have been deposited with accession code 2W2G (P2<sub>1</sub> crystal form) and 2WCT (P1 crystal form).</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="ppat.1000428.s001"><label>Figure S1</label><caption><p>Zone-interference gel electrophoresis experiment showing that SUD<sub>core</sub> fails to bind NAD&#x0002b; and ADP-ribose. SUD<sub>core</sub> alone (label 0) and decreasing concentrations (1, 0.5, 0.1, 0.05 and 0.02 mM) of NAD<sup>&#x0002b;</sup>, or decreasing concentrations (1, 0.5, 0.1, 0.05 and 0.02 mM) of ADP-ribose.</p><p>(0.70 MB DOC)</p></caption><media xlink:href="ppat.1000428.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000428.s002"><label>Figure S2</label><caption><p>Alternative models of G-quadruplex binding to SUD<sub>core</sub>, obtained by automated docking into the crystal structures. The SUD-N and SUD-M subdomains are in violet and cyan, respectively, the G-quadruplex as found in the <italic>bcl-2</italic> promoter region (PDB code: 2F8U) is in orange. The pairs of mutations in SUD-N are indicated by green (M1, K505A&#x0002b;K506A) and blue (M2, K476A&#x0002b;K477A) spheres. The M3 set of mutations in SUD-M is indicated by olive (K563A) and orange (K565A&#x0002b;K568A) spheres. The M4 set of mutations, also in SUD-M, is indicated by orange (K565A&#x0002b;K568A) and yellow (E571A) spheres. (A) A possible binding site is in a cleft between monomers in the SUD<sub>core</sub> dimer. The binding site is close to the lysine residues replaced by the M3 and M4 mutations, compatible with the inability of these mutants to bind G-quadruplexes. (B) A second potential binding site is a cleft between two neighboring SUD<sub>core</sub> dimers as found in both crystal packing arrangements (space groups P2<sub>1</sub> and P1). This binding mode is compatible with the observation of SUD<sub>core</sub> oligomerization upon G-quadruplex binding.</p><p>(3.46 MB DOC)</p></caption><media xlink:href="ppat.1000428.s002.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1000428.s003"><label>Table S1</label><caption><p>Primer sequences used for SUD-N, SUD-M, and four sets of mutants.</p><p>(0.01 MB PDF)</p></caption><media xlink:href="ppat.1000428.s003.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank D. Mutschall for expert technical assistance, and U. M&#x000fc;ller (BESSY, Berlin, Germany) as well as T. Ursby (MAX-lab, Lund, Sweden) and K.H.G. Verschueren for assistance with synchrotron data collection. This publication is dedicated to Professor Wolfram Saenger on the occasion of his 70<sup>th</sup> birthday.</p></ack><ref-list><title>References</title><ref id="ppat.1000428-Snijder1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snijder</surname><given-names>EJ</given-names></name><name><surname>Bredenbeek</surname><given-names>PJ</given-names></name><name><surname>Dobbe</surname><given-names>JC</given-names></name><name><surname>Thiel</surname><given-names>V</given-names></name><name><surname>Ziebuhr</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.</article-title><source>J Mol Biol</source><volume>331</volume><fpage>991</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">12927536</pub-id></citation></ref><ref id="ppat.1000428-Neuman1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neuman</surname><given-names>BW</given-names></name><name><surname>Joseph</surname><given-names>JS</given-names></name><name><surname>Saikatendu</surname><given-names>KS</given-names></name><name><surname>Serrano</surname><given-names>P</given-names></name><name><surname>Chatterjee</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3.</article-title><source>J Virol</source><volume>82</volume><fpage>5279</fpage><lpage>5294</lpage><pub-id pub-id-type="pmid">18367524</pub-id></citation></ref><ref id="ppat.1000428-Hilgenfeld1"><label>3</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hilgenfeld</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name></person-group><year>2008</year><article-title>Structural proteomics of emerging viruses: The examples of SARS-CoV and other coronaviruses.</article-title><person-group person-group-type="editor"><name><surname>Sussman</surname><given-names>JL</given-names></name><name><surname>Silman</surname><given-names>I</given-names></name></person-group><source>Structural proteomics and its impact on the life sciences</source><publisher-loc>Singapore</publisher-loc><publisher-name>World Scientific</publisher-name><fpage>361</fpage><lpage>433</lpage></citation></ref><ref id="ppat.1000428-Serrano1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>P</given-names></name><name><surname>Johnson</surname><given-names>MA</given-names></name><name><surname>Almeida</surname><given-names>MS</given-names></name><name><surname>Horst</surname><given-names>R</given-names></name><name><surname>Herrmann</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus.</article-title><source>J Virol</source><volume>81</volume><fpage>12049</fpage><lpage>12060</lpage><pub-id pub-id-type="pmid">17728234</pub-id></citation></ref><ref id="ppat.1000428-Ratia1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ratia</surname><given-names>K</given-names></name><name><surname>Saikatendu</surname><given-names>KS</given-names></name><name><surname>Santarsiero</surname><given-names>BD</given-names></name><name><surname>Barretto</surname><given-names>N</given-names></name><name><surname>Backer</surname><given-names>SC</given-names></name><etal/></person-group><year>2006</year><article-title>Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>5717</fpage><lpage>5722</lpage><pub-id pub-id-type="pmid">16581910</pub-id></citation></ref><ref id="ppat.1000428-Anand1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>K</given-names></name><name><surname>Ziebuhr</surname><given-names>J</given-names></name><name><surname>Wadhwani</surname><given-names>P</given-names></name><name><surname>Mesters</surname><given-names>JR</given-names></name><name><surname>Hilgenfeld</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>Coronavirus main proteinase (3CL<sup>pro</sup>) structure: Basis for design of anti-SARS drugs.</article-title><source>Science</source><volume>300</volume><fpage>1763</fpage><lpage>1767</lpage><pub-id pub-id-type="pmid">12746549</pub-id></citation></ref><ref id="ppat.1000428-Yang1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lou</surname><given-names>Z</given-names></name><etal/></person-group><year>2003</year><article-title>The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>13190</fpage><lpage>13195</lpage><pub-id pub-id-type="pmid">14585926</pub-id></citation></ref><ref id="ppat.1000428-Tan1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Verschueren</surname><given-names>KHG</given-names></name><name><surname>Anand</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>pH-dependent conformational flexibility of the SARS-CoV main proteinase (M<sup>pro</sup>) dimer: Molecular dynamics simulations and multiple X-ray structure analyses.</article-title><source>J Mol Biol</source><volume>354</volume><fpage>25</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16242152</pub-id></citation></ref><ref id="ppat.1000428-Sulea1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sulea</surname><given-names>T</given-names></name><name><surname>Lindner</surname><given-names>HA</given-names></name><name><surname>Purisima</surname><given-names>EO</given-names></name><name><surname>M&#x000e9;nard</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?</article-title><source>J Virol</source><volume>79</volume><fpage>4550</fpage><lpage>4551</lpage><pub-id pub-id-type="pmid">15767458</pub-id></citation></ref><ref id="ppat.1000428-Barretto1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barretto</surname><given-names>N</given-names></name><name><surname>Jukneliene</surname><given-names>D</given-names></name><name><surname>Ratia</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Mesecar</surname><given-names>AD</given-names></name><etal/></person-group><year>2005</year><article-title>The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.</article-title><source>J Virol</source><volume>79</volume><fpage>15189</fpage><lpage>15198</lpage><pub-id pub-id-type="pmid">16306590</pub-id></citation></ref><ref id="ppat.1000428-Lindner1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>HA</given-names></name><name><surname>Fotouhi-Ardakani</surname><given-names>N</given-names></name><name><surname>Lytvyn</surname><given-names>V</given-names></name><name><surname>Lachance</surname><given-names>P</given-names></name><name><surname>Sulea</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.</article-title><source>J Virol</source><volume>79</volume><fpage>15199</fpage><lpage>15208</lpage><pub-id pub-id-type="pmid">16306591</pub-id></citation></ref><ref id="ppat.1000428-Barretto2"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barretto</surname><given-names>N</given-names></name><name><surname>Jukneliene</surname><given-names>D</given-names></name><name><surname>Ratia</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Mesecar</surname><given-names>AD</given-names></name><etal/></person-group><year>2006</year><article-title>Deubiquitinating activity of the SARS-CoV papain-like protease.</article-title><source>Adv Exp Med Biol</source><volume>581</volume><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17037501</pub-id></citation></ref><ref id="ppat.1000428-Lindner2"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>HA</given-names></name><name><surname>Lytvyn</surname><given-names>V</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Lachance</surname><given-names>P</given-names></name><name><surname>Ziomek</surname><given-names>E</given-names></name><etal/></person-group><year>2007</year><article-title>Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease.</article-title><source>Arch Biochem Biophys</source><volume>466</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">17692280</pub-id></citation></ref><ref id="ppat.1000428-Kim1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KI</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><year>2003</year><article-title>ISG15, not just another ubiquitin-like protein.</article-title><source>Biochem Biophys Res Commun</source><volume>307</volume><fpage>431</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">12893238</pub-id></citation></ref><ref id="ppat.1000428-Ritchie1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>KJ</given-names></name><name><surname>Zhang</surname><given-names>DE</given-names></name></person-group><year>2004</year><article-title>ISG15: the immunological kin of ubiquitin.</article-title><source>Semin Cell Dev Biol</source><volume>15</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">15209384</pub-id></citation></ref><ref id="ppat.1000428-Devaraj1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devaraj</surname><given-names>SG</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Tseng</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>32208</fpage><lpage>32221</lpage><pub-id pub-id-type="pmid">17761676</pub-id></citation></ref><ref id="ppat.1000428-Pehrson1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pehrson</surname><given-names>JR</given-names></name><name><surname>Fried</surname><given-names>VA</given-names></name></person-group><year>1992</year><article-title>MacroH2A, a core histone containing a large nonhistone region.</article-title><source>Science</source><volume>257</volume><fpage>1398</fpage><lpage>1400</lpage><pub-id pub-id-type="pmid">1529340</pub-id></citation></ref><ref id="ppat.1000428-Kustatscher1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kustatscher</surname><given-names>G</given-names></name><name><surname>Hothorn</surname><given-names>M</given-names></name><name><surname>Pugieux</surname><given-names>C</given-names></name><name><surname>Scheffzek</surname><given-names>K</given-names></name><name><surname>Ladurner</surname><given-names>AG</given-names></name></person-group><year>2005</year><article-title>Splicing regulates NAD metabolite binding to histone macroH2A.</article-title><source>Nature Struct Mol Biol</source><volume>12</volume><fpage>624</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">15965484</pub-id></citation></ref><ref id="ppat.1000428-Chakravarthy1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakravarthy</surname><given-names>S</given-names></name><name><surname>Gundimella</surname><given-names>SK</given-names></name><name><surname>Caron</surname><given-names>C</given-names></name><name><surname>Perche</surname><given-names>PY</given-names></name><name><surname>Pehrson</surname><given-names>JR</given-names></name><etal/></person-group><year>2005</year><article-title>Structural characterization of the histone variant macroH2A.</article-title><source>Mol Cell Biol</source><volume>25</volume><fpage>7616</fpage><lpage>7624</lpage><pub-id pub-id-type="pmid">16107708</pub-id></citation></ref><ref id="ppat.1000428-Shull1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shull</surname><given-names>NP</given-names></name><name><surname>Spinelli</surname><given-names>SL</given-names></name><name><surname>Phizicky</surname><given-names>EM</given-names></name></person-group><year>2005</year><article-title>A highly specific phosphatase that acts on ADP-ribose 1&#x02033;-phosphate, a metabolite of tRNA splicing in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Nucleic Acids Res</source><volume>33</volume><fpage>650</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">15684411</pub-id></citation></ref><ref id="ppat.1000428-Putics1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Putics</surname><given-names>&#x000c1;</given-names></name><name><surname>Filipowicz</surname><given-names>W</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Gorbalenya</surname><given-names>AE</given-names></name><name><surname>Ziebuhr</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>ADP-ribose-1&#x02033;-monophosphatases: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture.</article-title><source>J Virol</source><volume>79</volume><fpage>12721</fpage><lpage>12731</lpage><pub-id pub-id-type="pmid">16188975</pub-id></citation></ref><ref id="ppat.1000428-Saikatendu1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saikatendu</surname><given-names>KS</given-names></name><name><surname>Joseph</surname><given-names>JS</given-names></name><name><surname>Subramanian</surname><given-names>V</given-names></name><name><surname>Clayton</surname><given-names>T</given-names></name><name><surname>Griffith</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1&#x02033;-phosphate dephosphorylation by a conserved domain of nsP3.</article-title><source>Structure</source><volume>13</volume><fpage>1665</fpage><lpage>1675</lpage><pub-id pub-id-type="pmid">16271890</pub-id></citation></ref><ref id="ppat.1000428-Egloff1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Egloff</surname><given-names>MP</given-names></name><name><surname>Malet</surname><given-names>H</given-names></name><name><surname>Putics</surname><given-names>&#x000c1;</given-names></name><name><surname>Heinonen</surname><given-names>M</given-names></name><name><surname>Dutartre</surname><given-names>H</given-names></name><etal/></person-group><year>2006</year><article-title>Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains.</article-title><source>J Virol</source><volume>80</volume><fpage>8493</fpage><lpage>8502</lpage><pub-id pub-id-type="pmid">16912299</pub-id></citation></ref><ref id="ppat.1000428-Piotrowski1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piotrowski</surname><given-names>Y</given-names></name><name><surname>Hansen</surname><given-names>G</given-names></name><name><surname>Boomaars-van der Zanden</surname><given-names>AL</given-names></name><name><surname>Snijder</surname><given-names>EJ</given-names></name><name><surname>Gorbalenya</surname><given-names>AE</given-names></name><etal/></person-group><year>2009</year><article-title>Crystal structures of the X-domains of a group-1 and a group-3 coronavirus reveal that ADP-ribose-binding may not be a conserved property.</article-title><source>Protein Sci</source><volume>18</volume><fpage>6</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">19177346</pub-id></citation></ref><ref id="ppat.1000428-Ponnusamy1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ponnusamy</surname><given-names>R</given-names></name><name><surname>Moll</surname><given-names>R</given-names></name><name><surname>Weimar</surname><given-names>T</given-names></name><name><surname>Mesters</surname><given-names>JR</given-names></name><name><surname>Hilgenfeld</surname><given-names>R</given-names></name></person-group><year>2008</year><article-title>Variable oligomerization modes in coronavirus non-structural protein 9.</article-title><source>J Mol Biol</source><volume>383</volume><fpage>1081</fpage><lpage>1096</lpage><pub-id pub-id-type="pmid">18694760</pub-id></citation></ref><ref id="ppat.1000428-Cao1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>TL</given-names></name></person-group><year>2008</year><article-title>Turkey coronavirus non-structure protein NSP15 - an endoribonuclease.</article-title><source>Intervirology</source><volume>51</volume><fpage>342</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">19023218</pub-id></citation></ref><ref id="ppat.1000428-Koonin1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koonin</surname><given-names>EV</given-names></name><name><surname>Gorbalenya</surname><given-names>AE</given-names></name><name><surname>Purdy</surname><given-names>MA</given-names></name><name><surname>Rozanov</surname><given-names>MN</given-names></name><name><surname>Reyes</surname><given-names>GR</given-names></name><etal/></person-group><year>1992</year><article-title>Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: Delineation of an additional group of positive-strand RNA plant and animal viruses.</article-title><source>Proc Natl Acad Sci U S A</source><volume>89</volume><fpage>8259</fpage><lpage>8263</lpage><pub-id pub-id-type="pmid">1518855</pub-id></citation></ref><ref id="ppat.1000428-Neuvonen1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neuvonen</surname><given-names>M</given-names></name><name><surname>Ahola</surname><given-names>T</given-names></name></person-group><year>2008</year><article-title>Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites.</article-title><source>J Mol Biol</source><volume>385</volume><fpage>212</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">18983849</pub-id></citation></ref><ref id="ppat.1000428-Chatterjee1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>MA</given-names></name><name><surname>Serrano</surname><given-names>P</given-names></name><name><surname>Pedrini</surname><given-names>B</given-names></name><name><surname>Joseph</surname><given-names>JJ</given-names></name><etal/></person-group><year>2009</year><article-title>Nuclear magnetic resonance structure shows that the SARS-unique domain contains a macrodomain fold.</article-title><source>J Virol</source><volume>83</volume><fpage>1823</fpage><lpage>1836</lpage><pub-id pub-id-type="pmid">19052085</pub-id></citation></ref><ref id="ppat.1000428-Putics2"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Putics</surname><given-names>&#x000c1;</given-names></name><name><surname>Slaby</surname><given-names>J</given-names></name><name><surname>Filipowicz</surname><given-names>W</given-names></name><name><surname>Gorbalenya</surname><given-names>AE</given-names></name><name><surname>Ziebuhr</surname><given-names>J</given-names></name></person-group><year>2006</year><article-title>ADP-ribose-1&#x02033;-phosphatase activities of the human coronavirus 229E and SARS coronavirus X domains.</article-title><source>Adv Exp Med Biol</source><volume>581</volume><fpage>93</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">17037511</pub-id></citation></ref><ref id="ppat.1000428-Tan2"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Kusov</surname><given-names>Y</given-names></name><name><surname>Mutschall</surname><given-names>D</given-names></name><name><surname>Tech</surname><given-names>S</given-names></name><name><surname>Nagarajan</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>The &#x0201c;SARS-unique&#x0201d; domain (SUD) of SARS coronavirus is an oligo(G)-binding protein.</article-title><source>Biochem Biophys Res Commun</source><volume>364</volume><fpage>877</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">17976532</pub-id></citation></ref><ref id="ppat.1000428-Keniry1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keniry</surname><given-names>MA</given-names></name></person-group><year>2001</year><article-title>Quadruplex structures in nucleic acids.</article-title><source>Biopolymers</source><volume>56</volume><fpage>123</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">11745109</pub-id></citation></ref><ref id="ppat.1000428-Dai1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>RA</given-names></name><name><surname>Hurley</surname><given-names>LH</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name></person-group><year>2006</year><article-title>NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region.</article-title><source>Nucleic Acids Res</source><volume>34</volume><fpage>5133</fpage><lpage>5144</lpage><pub-id pub-id-type="pmid">16998187</pub-id></citation></ref><ref id="ppat.1000428-Hew1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hew</surname><given-names>Y</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Grzelczak</surname><given-names>Z</given-names></name><name><surname>Keeley</surname><given-names>FW</given-names></name></person-group><year>2000</year><article-title>Identification of a GA-rich sequence as a protein-binding site in the 3&#x02032;-untranslated region of chicken elastin mRNA with a potential role in the developmental regulation of elastin mRNA stability.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>24857</fpage><lpage>24864</lpage><pub-id pub-id-type="pmid">10829024</pub-id></citation></ref><ref id="ppat.1000428-Pan1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>B</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>K</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Sundaralingam</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Crystal structure of an RNA purine-rich tetraplex containing adenine tetrads: Implications for specific binding in RNA tetraplexes.</article-title><source>Structure</source><volume>11</volume><fpage>815</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">12842044</pub-id></citation></ref><ref id="ppat.1000428-Deng1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Sundaralingam</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>X-ray analysis of an RNA tetraplex (UGGGGU)<sub>4</sub> with divalent Sr<sup>2&#x0002b;</sup> ions at subatomic resolution (0.61 &#x000c5;).</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>13665</fpage><lpage>13670</lpage><pub-id pub-id-type="pmid">11707581</pub-id></citation></ref><ref id="ppat.1000428-Prentice1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prentice</surname><given-names>E</given-names></name><name><surname>Jerome</surname><given-names>WG</given-names></name><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Denison</surname><given-names>MR</given-names></name></person-group><year>2004</year><article-title>Coronavirus replication complex formation utilizes components of cellular autophagy.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>10136</fpage><lpage>10141</lpage><pub-id pub-id-type="pmid">14699140</pub-id></citation></ref><ref id="ppat.1000428-Snijder2"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snijder</surname><given-names>EJ</given-names></name><name><surname>van der Meer</surname><given-names>Y</given-names></name><name><surname>Zevenhoven-Dobbe</surname><given-names>J</given-names></name><name><surname>Onderwater</surname><given-names>JJ</given-names></name><name><surname>van der Meulen</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex.</article-title><source>J Virol</source><volume>80</volume><fpage>5927</fpage><lpage>5940</lpage><pub-id pub-id-type="pmid">16731931</pub-id></citation></ref><ref id="ppat.1000428-vanHemert1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Hemert</surname><given-names>MJ</given-names></name><name><surname>van den Worm</surname><given-names>SHE</given-names></name><name><surname>Knoops</surname><given-names>K</given-names></name><name><surname>Mommaas</surname><given-names>AM</given-names></name><name><surname>Gorbalenya</surname><given-names>AE</given-names></name><etal/></person-group><year>2008</year><article-title>SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity <italic>in vitro</italic>.</article-title><source>PLoS Pathog</source><volume>4</volume><fpage>e1000054</fpage><comment>doi:10.1371/journal.ppat.1000054</comment><pub-id pub-id-type="pmid">18451981</pub-id></citation></ref><ref id="ppat.1000428-Knoops1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knoops</surname><given-names>K</given-names></name><name><surname>Kikkert</surname><given-names>M</given-names></name><name><surname>van den Worm</surname><given-names>SHE</given-names></name><name><surname>Zevenhoven-Dobbe</surname><given-names>JC</given-names></name><name><surname>van der Meer</surname><given-names>Y</given-names></name><etal/></person-group><year>2008</year><article-title>SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum.</article-title><source>PLoS Biol</source><volume>6</volume><fpage>e226</fpage><comment>doi:10.1371/journal.pbio.0060226</comment><pub-id pub-id-type="pmid">18798692</pub-id></citation></ref><ref id="ppat.1000428-Eleouet1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eleouet</surname><given-names>JF</given-names></name><name><surname>Chilmonczyk</surname><given-names>S</given-names></name><name><surname>Besnardeau</surname><given-names>L</given-names></name><name><surname>Laude</surname><given-names>H</given-names></name></person-group><year>1998</year><article-title>Transmissible gastroenteritis coronavirus induces programmed cell death in infected cells through a caspase-dependent pathway.</article-title><source>J Virol</source><volume>72</volume><fpage>4918</fpage><lpage>4924</lpage><pub-id pub-id-type="pmid">9573259</pub-id></citation></ref><ref id="ppat.1000428-Wu1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YH</given-names></name><name><surname>Tseng</surname><given-names>CP</given-names></name><name><surname>Cheng</surname><given-names>ML</given-names></name><name><surname>Ho</surname><given-names>HY</given-names></name><name><surname>Shih</surname><given-names>SR</given-names></name><etal/></person-group><year>2008</year><article-title>Glucose-6-Phosphate dehydrogenase deficiency enhances human coronavirus 229E infection.</article-title><source>J Infect Dis</source><volume>197</volume><fpage>812</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">18269318</pub-id></citation></ref><ref id="ppat.1000428-Imai1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Kuba</surname><given-names>K</given-names></name><name><surname>Neely</surname><given-names>GG</given-names></name><name><surname>Yaghubian-Malhami</surname><given-names>R</given-names></name><name><surname>Perkmann</surname><given-names>T</given-names></name><etal/></person-group><year>2008</year><article-title>Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.</article-title><source>Cell</source><volume>133</volume><fpage>235</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">18423196</pub-id></citation></ref><ref id="ppat.1000428-Xu1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><etal/></person-group><year>2009</year><article-title>Crystal structures of two coronavirus ADP-ribose-1&#x02033;-monophosphatases and their complexes with ADP-ribose: a systematic structural analysis of the viral ADRP domain.</article-title><source>J Virol</source><volume>83</volume><fpage>1083</fpage><lpage>1092</lpage><pub-id pub-id-type="pmid">18987156</pub-id></citation></ref><ref id="ppat.1000428-Wie1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wie</surname><given-names>JS</given-names></name><name><surname>Whiteford</surname><given-names>CC</given-names></name><name><surname>Cenacchi</surname><given-names>N</given-names></name><name><surname>Son</surname><given-names>CG</given-names></name><name><surname>Khan</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>BBC3 mediates fenretinide-induced cell death in neuroblastoma.</article-title><source>Oncogene</source><volume>24</volume><fpage>7976</fpage><lpage>7983</lpage><pub-id pub-id-type="pmid">16091745</pub-id></citation></ref><ref id="ppat.1000428-GarciaSaez1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Saez</surname><given-names>I</given-names></name><name><surname>Tcherniuk</surname><given-names>S</given-names></name><name><surname>Kozielski</surname><given-names>F</given-names></name></person-group><year>2006</year><article-title>The structure of human neuronal Rab6B in the active and inactive form.</article-title><source>Acta Crystallogr D</source><volume>62</volume><fpage>725</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">16790928</pub-id></citation></ref><ref id="ppat.1000428-Mizutani1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizutani</surname><given-names>T</given-names></name></person-group><year>2007</year><article-title>Signal transduction in SARS-CoV-infected cells.</article-title><source>Ann N Y Acad Sci</source><volume>1102</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">17470913</pub-id></citation></ref><ref id="ppat.1000428-Jin1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>G</given-names></name><name><surname>Klika</surname><given-names>A</given-names></name><name><surname>Callahan</surname><given-names>M</given-names></name><name><surname>Faga</surname><given-names>B</given-names></name><name><surname>Danzig</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Identification of a human NF-&#x003ba;B-activating protein, TAB3.</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>2028</fpage><lpage>2033</lpage><pub-id pub-id-type="pmid">14766965</pub-id></citation></ref><ref id="ppat.1000428-Hakm1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hakm&#x000e9;</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>A</given-names></name><name><surname>Doll&#x000e9;</surname><given-names>P</given-names></name><name><surname>Schreiber</surname><given-names>V</given-names></name></person-group><year>2008</year><article-title>The macroPARP genes <italic>Parp-9</italic> and <italic>Parp-14</italic> are developmentally and differentially regulated in mouse tissues.</article-title><source>Dev Dyn</source><volume>237</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">18069692</pub-id></citation></ref><ref id="ppat.1000428-Brkle1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>B&#x000fc;rkle</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Poly(ADP-ribose): The most elaborate metabolite of NAD<sup>&#x0002b;</sup>.</article-title><source>FEBS J</source><volume>272</volume><fpage>4576</fpage><lpage>4589</lpage><pub-id pub-id-type="pmid">16156780</pub-id></citation></ref><ref id="ppat.1000428-Schreiber1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>V</given-names></name><name><surname>Dantzer</surname><given-names>F</given-names></name><name><surname>Ame</surname><given-names>JC</given-names></name><name><surname>de Murcia</surname><given-names>G</given-names></name></person-group><year>2006</year><article-title>Poly(ADP-ribose): novel functions for an old molecule.</article-title><source>Nature Rev Mol Cell Biol</source><volume>7</volume><fpage>517</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">16829982</pub-id></citation></ref><ref id="ppat.1000428-Hassa1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassa</surname><given-names>PO</given-names></name><name><surname>Hottiger</surname><given-names>MO</given-names></name></person-group><year>2008</year><article-title>The diverse biological roles of mammalian PARPs, a small but powerful family of poly-ADP-ribose polymerases.</article-title><source>Front Biosci</source><volume>13</volume><fpage>3046</fpage><lpage>3082</lpage><pub-id pub-id-type="pmid">17981777</pub-id></citation></ref><ref id="ppat.1000428-Ruf1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruf</surname><given-names>A</given-names></name><name><surname>de Murcia</surname><given-names>JM</given-names></name><name><surname>de Murcia</surname><given-names>G</given-names></name><name><surname>Schulz</surname><given-names>GE</given-names></name></person-group><year>1996</year><article-title>Structure of the catalytic fragment of poly(ADP-ribose) polymerase from chicken.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>7481</fpage><lpage>7485</lpage><pub-id pub-id-type="pmid">8755499</pub-id></citation></ref><ref id="ppat.1000428-Soldatenkov1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soldatenkov</surname><given-names>VA</given-names></name><name><surname>Vetcher</surname><given-names>AA</given-names></name><name><surname>Duka</surname><given-names>T</given-names></name><name><surname>Ladame</surname><given-names>S</given-names></name></person-group><year>2008</year><article-title>First evidence of a functional interaction between DNA quadruplexes and poly(ADP-ribose) polymerase-1.</article-title><source>ACS Chem Biol</source><volume>3</volume><fpage>214</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">18338862</pub-id></citation></ref><ref id="ppat.1000428-vanZon1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Zon</surname><given-names>A</given-names></name><name><surname>Mossink</surname><given-names>MH</given-names></name><name><surname>Schoester</surname><given-names>M</given-names></name><name><surname>Houtsmuller</surname><given-names>AB</given-names></name><name><surname>Scheffer</surname><given-names>GL</given-names></name><etal/></person-group><year>2003</year><article-title>The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.</article-title><source>J Cell Sci</source><volume>116</volume><fpage>4391</fpage><lpage>4400</lpage><pub-id pub-id-type="pmid">13130096</pub-id></citation></ref><ref id="ppat.1000428-Kerns1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerns</surname><given-names>JA</given-names></name><name><surname>Emerman</surname><given-names>M</given-names></name><name><surname>Malik</surname><given-names>HS</given-names></name></person-group><year>2008</year><article-title>Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein.</article-title><source>PLoS Genet</source><volume>4</volume><fpage>e21</fpage><comment>doi:10.1371/journal.pgen.0040021</comment><pub-id pub-id-type="pmid">18225958</pub-id></citation></ref><ref id="ppat.1000428-GoilaGaur1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goila-Gaur</surname><given-names>R</given-names></name><name><surname>Strebel</surname><given-names>K</given-names></name></person-group><year>2008</year><article-title>HIV-1 vif, APOBEC, and intrinsic immunity.</article-title><source>Retrovirol</source><volume>5</volume><fpage>51</fpage></citation></ref><ref id="ppat.1000428-Ouararhni1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ouararhni</surname><given-names>K</given-names></name><name><surname>Hadj-Slimane</surname><given-names>R</given-names></name><name><surname>Ait-Si-Ali</surname><given-names>S</given-names></name><name><surname>Robin</surname><given-names>P</given-names></name><name><surname>Mietton</surname><given-names>F</given-names></name><etal/></person-group><year>2006</year><article-title>The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity.</article-title><source>Genes Dev</source><volume>20</volume><fpage>3324</fpage><lpage>3336</lpage><pub-id pub-id-type="pmid">17158748</pub-id></citation></ref><ref id="ppat.1000428-Leslie1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname><given-names>AGW</given-names></name></person-group><year>1992</year><article-title>Recent changes to the MOSFLM package for processing film and image plate data.</article-title><source>Joint CCP4&#x0002b;ESF&#x02013;EAMCB Newsletter on Protein Crystallography</source><volume>26</volume><fpage>27</fpage><lpage>33</lpage></citation></ref><ref id="ppat.1000428-Evans1"><label>60</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>PR</given-names></name></person-group><year>1993</year><article-title>Data reduction.</article-title><person-group person-group-type="editor"><name><surname>Sawyer</surname><given-names>L</given-names></name><name><surname>Isaacs</surname><given-names>N</given-names></name><name><surname>Bailey</surname><given-names>S</given-names></name></person-group><source>Proceedings of the CCP4 Study Weekend. Data Collection and Processing</source><publisher-loc>Warrington</publisher-loc><publisher-name>Daresbury Laboratory</publisher-name><fpage>114</fpage><lpage>122</lpage></citation></ref><ref id="ppat.1000428-Collaborative1"><label>61</label><citation citation-type="journal"><collab>Collaborative Computational Project, Number 4</collab><year>1994</year><article-title>The CCP4 suite: Programs for protein crystallography.</article-title><source>Acta Crystallogr D</source><volume>50</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">15299374</pub-id></citation></ref><ref id="ppat.1000428-Matthews1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>BW</given-names></name></person-group><year>1968</year><article-title>Solvent content of protein crystals.</article-title><source>J Mol Biol</source><volume>33</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">5700707</pub-id></citation></ref><ref id="ppat.1000428-Chatterjee2"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>MA</given-names></name><name><surname>Serrano</surname><given-names>P</given-names></name><name><surname>Pedrini</surname><given-names>B</given-names></name><name><surname>W&#x000fc;thrich</surname><given-names>K</given-names></name></person-group><year>2007</year><article-title>NMR assignment of the domain 513-651 from the SARS-CoV nonstructural protein nsp3.</article-title><source>Biomol NMR Assign</source><volume>1</volume><fpage>191</fpage><lpage>194</lpage></citation></ref><ref id="ppat.1000428-McCoy1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name></person-group><year>2005</year><article-title>Likelihood-enhanced fast translation functions.</article-title><source>Acta Crystallogr D</source><volume>61</volume><fpage>458</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">15805601</pub-id></citation></ref><ref id="ppat.1000428-McCoy2"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><etal/></person-group><year>2007</year><article-title>Phaser crystallographic software.</article-title><source>J Appl Cryst</source><volume>40</volume><fpage>658</fpage><lpage>674</lpage></citation></ref><ref id="ppat.1000428-Bricogne1"><label>66</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Bricogne</surname><given-names>G</given-names></name><name><surname>Blanc</surname><given-names>E</given-names></name><name><surname>Brandl</surname><given-names>M</given-names></name><name><surname>Flensburg</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><etal/></person-group><year>2008</year><source>BUSTER-TNT, version 2.5.1</source><publisher-loc>Cambridge, United Kingdom</publisher-loc><publisher-name>Global Phasing Ltd</publisher-name></citation></ref><ref id="ppat.1000428-Smart1"><label>67</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Smart</surname><given-names>OS</given-names></name><name><surname>Brandl</surname><given-names>M</given-names></name><name><surname>Flensburg</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><name><surname>Paciorek</surname><given-names>W</given-names></name><etal/></person-group><year>2008</year><fpage>137</fpage><comment>Annual Meeting of the American Crystallographic Association, Knoxville, TN. Abstract TP139</comment></citation></ref><ref id="ppat.1000428-Cowtan1"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year>1994</year><article-title>DM: an automated procedure for phase improvement by density modification.</article-title><source>Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography</source><volume>31</volume><fpage>34</fpage><lpage>38</lpage></citation></ref><ref id="ppat.1000428-Vellieux1"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vellieux</surname><given-names>FMD</given-names></name><name><surname>Hunt</surname><given-names>JF</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name></person-group><year>1995</year><article-title>DEMON/ANGEL: a suite of programs to carry out density modification.</article-title><source>J Appl Cryst</source><volume>28</volume><fpage>347</fpage><lpage>351</lpage></citation></ref><ref id="ppat.1000428-Cowtan2"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year>2006</year><article-title>The Buccaneer software for automated model building.</article-title><source>Acta Crystallogr D</source><volume>62</volume><fpage>1002</fpage><lpage>1011</lpage><pub-id pub-id-type="pmid">16929101</pub-id></citation></ref><ref id="ppat.1000428-Murshudov1"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group><year>1997</year><article-title>Refinement of macromolecular structures by the maximum-likelihood method.</article-title><source>Acta Crystallogr D</source><volume>53</volume><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">15299926</pub-id></citation></ref><ref id="ppat.1000428-Potterton1"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potterton</surname><given-names>E</given-names></name><name><surname>Briggs</surname><given-names>P</given-names></name><name><surname>Turkenburg</surname><given-names>M</given-names></name><name><surname>Dodson</surname><given-names>E</given-names></name></person-group><year>2003</year><article-title>A graphical user interface to the CCP4 program suite.</article-title><source>Acta Crystallogr D</source><volume>59</volume><fpage>1131</fpage><lpage>1137</lpage><pub-id pub-id-type="pmid">12832755</pub-id></citation></ref><ref id="ppat.1000428-Kabsch1"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W</given-names></name></person-group><year>1993</year><article-title>Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants.</article-title><source>J Appl Cryst</source><volume>26</volume><fpage>795</fpage><lpage>800</lpage></citation></ref><ref id="ppat.1000428-Vagin1"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vagin</surname><given-names>A</given-names></name><name><surname>Teplyakov</surname><given-names>A</given-names></name></person-group><year>1997</year><article-title>MOLREP: an automated program for molecular replacement.</article-title><source>J Appl Cryst</source><volume>30</volume><fpage>1022</fpage><lpage>1025</lpage></citation></ref><ref id="ppat.1000428-Emsley1"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Coot: Model-building tools for molecular graphics.</article-title><source>Acta Crystallogr D</source><volume>60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="pmid">15572765</pub-id></citation></ref><ref id="ppat.1000428-DeLano1"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeLano</surname><given-names>WL</given-names></name></person-group><year>2002</year><comment>The PyMOL molecular graphics system. DeLano Scientific, Palo Alto, CA, USA</comment></citation></ref><ref id="ppat.1000428-Abrahams1"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrahams</surname><given-names>JP</given-names></name><name><surname>Kraal</surname><given-names>B</given-names></name><name><surname>Bosch</surname><given-names>L</given-names></name></person-group><year>1988</year><article-title>Zone-interference gel electrophoresis: a new method for studying weak protein-nucleic acid complexes under native equilibrium conditions.</article-title><source>Nucleic Acids Res</source><volume>16</volume><fpage>10099</fpage><lpage>10108</lpage><pub-id pub-id-type="pmid">3194195</pub-id></citation></ref><ref id="ppat.1000428-Weiss1"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>MS</given-names></name><name><surname>Hilgenfeld</surname><given-names>R</given-names></name></person-group><year>1997</year><article-title>On the use of the merging R-factor as a quality indicator for X-ray data.</article-title><source>J Appl Cryst</source><volume>30</volume><fpage>203</fpage><lpage>205</lpage></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This work was supported by the Sino-European Project on SARS Diagnostics and Antivirals (SEPSDA) of the European Commission, contract number SP22-CT-2004-003831; VIZIER project of the European Commission, contract number LSHG-CT-2004-511960; OptiCryst project of the European Commission, contract number LSH-2005-037793; Sino-German Center for the Promotion of Research, Beijing, China, GZ 236 (202/9); DFG Cluster of Excellence &#x0201c;Inflammation at Interfaces&#x0201d;; Schleswig-Holstein Innovation Fund; and Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 